pic1.cmt.com.cnpic1.cmt.com.cn/newspic/files/2013AHA会议日程.pdfPurchase Sessions OnDemand™ Premium today and save $200 — in Lobby C and HeartQuarters Booth 339 TRACKS TIME

Purchase Sessions OnDemand™ Premium today and save $200 — in Lobby C and HeartQuarters Booth 339

TRACKS

TIME SESSION TITLE ROOM

Scientific Sessions integrates four broad areas of basic, translational, clinical and population sciences into its more than 5,000 presentations. To assist you in navigating the meeting, Scientific Sessions offers 26 program tracks. These tracks allow you to focus your education in your specialty or expand your knowledge in other areas.

Tracks

TRACK

ACUTE CORONARY SYNDROME

ATHEROSCLEROSIS AND THROMBOSIS

CARDIAC STRUCTURE AND FUNCTION

CARDIOPULMONARY RESUSCITATION

CARDIOVASCULAR AND STROKE NURSING

CARDIOVASCULAR STEM CELL BIOLOGY AND DEVELOPMENT

CONGENITAL HEART DEFECTS, CHILDREN AND HEALTH THROUGHOUT THE LIFE SPAN

DIABETES, LIPIDS AND CARDIOMETABOLIC SYNDROME

EARLY CAREER/PROFESSIONAL DEVELOPMENT

ELECTROPHYSIOLOGY

GENERAL CARDIOLOGY AND STRUCTURAL HEART DISEASE

GENETICS/GENOMICS

GLOBAL CONGRESS ON PHYSICAL ACTIVITY

HEART FAILURE

HYPERTENSION AND KIDNEY DISEASE

IMAGING

INTERVENTIONAL CARDIOLOGY

MYOCYTE SIGNALING AND ION CHANNELS

PERIPHERAL VASCULAR DISEASE

PHARMACOLOGY

PREVENTION, BEHAVIOR CHANGE AND HEALTHY LIFESTYLES

PULMONARY & SYSTEMIC VASCULAR BIOLOGY AND DISEASE

QUALITY OF CARE OUTCOMES AND EPIDEMIOLOGY

STROKE AND CEREBROVASCULAR DISEASE

SURGERY

SYSTEMS BIOLOGY/PHYSIOLOGY, INCLUDING OMICS

Basic Science Clinical ScienceTranslational Science Population Science

70 Join or renew your AHA/ASA Professional Membership onsite and receive a free gift in HeartQuarters Booth 339

TRACKS


Trac

ks

ACUTE CORONARY SYNDROMESunday Nov 17

8:00-9:30 SMP.602 Reperfusion Strategies for STEMI: Around the World Room D226

8:00-11:00 SMP.702 Is It Time to Think Bigger About Microvascular Disease in the Heart? Room C146

9:00-5:00 APS.216.04 Clinical and Hospital-Based Observational Studies Hall F, Core 2

APS.212.02 Markers for Prognosis in CVD I Hall F, Core 2

APS.710.01 Myocardial Infarction: Novel Mechanisms of Injury and Repair Hall F, Core 7

APS.725.01 Novel Insights into the Management of ACS: Quality of Care and Outcomes Hall F, Core 7

APS.716.02 Novel Therapeutic Strategies and Approaches to Risk Stratification for Patients with ACS Hall F, Core 7

APS.727.01 Risk Factors I Hall F, Core 7

APS.702.05 Risk Factors, Mortality and Mechanisms of Atherosclerosis Hall F, Core 7

APS.702.01 Role of Macrophages and Other Leukocytes in Atherosclerosis Hall F, Core 7

APS.715.01 Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology Hall F, Core 7

9:30-11:00 SMP.603 Interventional Cardiology: The Best Trials of 2013 Room D226

4:00-5:19 LBCT.01 Acute Cardiovascular and Cerebrovascular Care Hall E

5:30-6:45 CVS.729 Joint AHA/Oman Heart Association Session: Reperfusion in STEMI— Achievements and Challenges

Room D227

Monday Nov 18

9:00-11:55 AOS.211.02 Still the One: Population Burden and Trends of CVD Room D162

9:00-12:00 AOS.705.01F Optimizing Stem Cell Repair in Models of Disease Room C146

AOS.709.01N Sol Sherry Distinguished Lecture in Thrombosis and Treatment of Thrombotic Disease Room C140

9:00-12:10 AOS.725.01 Acute Coronary Syndrome Care and Complications: Quality Care and Outcomes Room C143

AOS.206.01 Cardiometabolic Effects of Popular Diets Room D167

9:00-5:00 APS.715.02 Atherogenesis and Myocardial Injury Hall F, Core 7

APS.606.03 Catheter-Based Coronary Imaging and Hemodynamics III Hall F, Core 6

APS.216.01 Clinical and Hospital-Based Observational Studies: Acute Coronary Syndrome and Percutaneous Coronary Intervention

Hall F, Core 2

APS.602.03 Coronary Interventions: Risky Patients and Risky Lesions Hall F, Core 6

APS.303.01 From Genomic Target to Disease Mechanism Hall F, Core 3

APS.726.01 Hyperhomocysteinemia and Vascular Reactivity Hall F, Core 7

APS.213.02 Improving Care in ACS, PCI and Cardiovascular Surgery Hall F, Core 2

APS.717.01 Ischemic Heart Disease: Diagnosis and Prognosis Hall F, Core 7

APS.212.03 Markers for Prognosis in CVD II Hall F, Core 2

APS.708.01 Microcirculation and Cerebral/Coronary/Peripheral Circulation Hall F, Core 7

APS.706.01 Novel Mechanisms and Therapeutics in Angiogenesis Part I Hall F, Core 7

APS.702.06h Risk Factors and Systemic Mediators of Atherosclerosis Hall F, Core 7

APS.727.02 Risk Factors II Hall F, Core 7

APS.702.02 Role of Smooth Muscle Cells and Endothelium in Atherosclerosis Hall F, Core 7

APS.716.03 Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy Hall F, Core 7

2:00-3:15 CVS.606 Primary PCI: State of the Art Room D226

2:00-4:55 AOS.704.01 Proliferation, Remodeling, Extracellular Matrix I Room C146

2:00-5:10 AOS.727.01 Risk Factors Room C144

AOS.608.01 Surgical Revascularization for Ischemic Heart Disease I Room D227

AOS.715.01 Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology Room C140

3:45-5:13 LBCT.04 Therapeutic Advances in Coronary and Peripheral Vascular Disease Ballrooms C1&C2

71 Purchase Sessions OnDemand™ Premium today and save $200 — in Lobby C and HeartQuarters Booth 339

TRACKS


Tracks

ACUTE CORONARY SYNDROME (cont.)5:30-6:45 CVS.407 Impact of Medical Gases on Ischemia-Reperfusion and Cardiac Arrest Outcomes Hall B-2

Tuesday Nov 19

7:30-8:45 CVS.108 In Search of the Culprit Lesion: Utility of Imaging Elm Fork Room

9:00-12:10 AOS.106.01 CT Imaging of Coronary Atherosclerosis Clear Fork Room

AOS.716.01N Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non–ST-Elevation ACS

Room C143

AOS.603.01 Novel Approaches and Technologies in AMI and Coronary Intervention Room D223

AOS.502.01 Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure Hall B-5

AOS.207.01 Physical Activity/Exercise Benefits: From Childhood to End-Stage Disease Room D163

9:00-5:00 APS.728.01 Biomarkers Hall F, Core 7

APS.602.05 Catheter-Based Coronary Interventions: Technologies and Outcomes Hall F, Core 6

APS.216.02 Clinical and Hospital-Based Observational Studies: CVD Risk Factors Hall F, Core 2

APS.210.04 Diabetes Mellitus and CVD: Clinical Outcomes Hall F, Core 2

APS.210.02 Diabetes Mellitus and CVD: Clinical Studies and Interventional Cardiology Hall F, Core 2

APS.717.02h Ischemic Heart Disease: Treatment and Mechanisms Hall F, Core 7

APS.702.03 Lipoproteins and Systemic Regulation of Atherosclerosis Hall F, Core 7

APS.212.04 Markers for Prognosis in CVD III Hall F, Core 2

APS.709.02 Mechanisms of Coagulation and Thrombosis Hall F, Core 7

APS.708.02h Microcirculation and Cerebral/Coronary/Peripheral Circulation Hall F, Core 7

APS.709.01 New Concepts in Platelet Function Hall F, Core 7

APS.706.02 Novel Mechanisms and Therapeutics in Angiogenesis Part II Hall F, Core 7

APS.704.03 Proliferation, Remodeling, Extracellular Matrix II Hall F, Core 7

APS.716.01 Systems of Care and Prognostic Indicators for Acute ST-Elevation Myocardial Infarction Hall F, Core 7

APS.602.04 The Spectrum of PCI: From Acute Coronary Syndromes to Chronic Occlusions Hall F, Core 6

APS.705.02 Translational and Clinical Studies of Cardiovascular Stem Cells Hall F, Core 7

2:00-5:00 AOS.702.01N Russell Ross Memorial Lectureship in Vascular Biology and Mechanisms of Atherosclerosis Room C143

2:00-5:10 AOS.216.01 Novel Insights into CVD Treatments and Outcomes from Observational Studies Room D163

5:30-6:45 CVS.619 Joint AHA/Caribbean Cardiac Society Joint Session: Barriers to Adoption of New Pharmacologies in ACS Management—US and International Perspectives

Room D222

Wednesday Nov 20

7:30-8:45 CVS.725 Depression: Status as a Risk Factor in Acute Coronary Syndromes Room C144

ATE.104 “Extreme” Imaging Elm Fork Room

CVS.225 Joint AHA/Mexican Society of Cardiology: “Looking South in Cardiovascular Disease” Room D162

9:00-12:00 APS.728.03h Biomarkers in Cardiac Disease and Diabetes Hall F, Core 7

APS.702.04 Gene Regulation and Soluble Mediators of Atherosclerosis Hall F, Core 7

APS.709.03 Hemostasis, Thrombosis and Coagulation Hall F, Core 7

APS.212.05 Markers for Prognosis in CVD IV Hall F, Core 2

APS.608.02 Surgical Revascularization for Ischemic Heart Disease III Hall F, Core 6

9:00-12:10 AOS.109.01 Noncoronary Vascular Imaging Clear Fork Room

10:45-12:15 CS.04 Advanced Cardiovascular Disease: Complications and Challenges Ballrooms C1&C2


TRACKS


Trac

ks

ATHEROSCLEROSIS AND THROMBOSISSunday Nov 17

8:00-11:00 SMP.205 Clinical Lipidology: Controversies in Cardiovascular Risk Reduction Room D167

SMP.702 Is It Time to Think Bigger About Microvascular Disease in the Heart? Room C146

SMP.302 Looking into a Crystal Ball: The Future of Genetics and Genomics Ballroom A2

SMP.201 New Scientific Advances That Support Food-Based Dietary Recommendations Room D162

SMP.202 Novel Therapeutics and Strategies in Type 2 Diabetes and CVD Room D170

SMP.704 Obesity in CVD Room C140

SMP.701 The Inflammasome Pathway in Cardiovascular and Metabolic Disease— Basic Science to Clinical Trials

Room C144

SMP.701 The Inflammasome Pathway in Cardiovascular and Metabolic Disease— Basic Science to Clinical Trials

Room C144

SMP.801 Groundbreaking Studies in the Practice of Cardiovascular Medicine: Circulation Editors' Choices Room D227

9:00-5:00 APS.606.01 Catheter-Based Coronary Imaging and Hemodynamics I Hall F, Core 6

APS.606.02 Catheter-Based Coronary Imaging and Hemodynamics II Hall F, Core 6

APS.604.01 Claudication, Aortoiliac Disease, Ankle Brachial Index Hall F, Core 6

APS.105.02 Clinical Nuclear Cardiology: Expanding Evidence and Applications Hall F, Core 1


APS.705.01 Controlling and Observing Stem Cell Behavior Hall F, Core 7

APS.106.02 CT Imaging of Coronary Atherosclerosis II Hall F, Core 1

APS.714.03 Femoropopliteal Artery Stenting; Restenosis Hall F, Core 7

APS.202.05 Lipoprotein Metabolism: Clinical and Population Studies Hall F, Core 2

APS.201.01 Mechanisms and Regulation of Hepatic Lipid Metabolism Hall F, Core 2

APS.721.01 Mechanisms of Brain Injury and Protection Hall F, Core 7


APS.703.01 Oxidative Stress and Endothelial Function Hall F, Core 7

APS.301.01 Regulation of Gene Expression in the Vascular System Hall F, Core 3

APS.704.01 Remodeling, Extracellular Matrix, Aortic Disease Hall F, Core 7




APS.201.02 Targeted Modulation of Lipid Metabolism Hall F, Core 2

APS.105.01 Translational Molecular Imaging: Novel Probes and Advanced Clinical Applications Hall F, Core 1


3:45-5:00 SS.01 Best of AHA Specialty Conferences Room C147

AOS.903.01Y ATVB Early Career Investigator Award Finalists Room C140

5:30-6:45 CVS.203 Brown Adipose Tissue: Its Renaissance and Relevance to Cardiovascular Health Room D163

CVS.705 Hard Issues on Soft Tissues: Contributing Cells in Vascular Calcification Room C144

CVS.204 Joint AHA/International Atherosclerosis Society Session: Should HDL Be a Target? Room D167

CVS.701 Latest Advances in Oxidative Stress Mechanisms of Metabolic Diseases Room C146

CVS.703 Leukocytes as Drivers of Atherosclerosis: Recent Advances Room C140

CVS.702 Mechanisms and Obstacles in Removal of Cholesterol from Atherosclerotic Plaques Room C150

CVS.101 State of the Art in Cardiac Computed Tomography Elm Fork Room


TRACKS


Tracks

Monday Nov 18

7:30-8:45 CVS.706 Inflammation, Immunity and Hypertension Room C150

CVS.707 Maintaining Hemostasis on Antithrombotic Therapy Room C146

CVS.206 Pathway-Selective Insulin Resistance and Cardiovascular Complications: How High Levels of Insulin Can Cause Harm

Room D163

9:00-12:00 AOS.105.01F Emerging Role of PET Biomarkers in Cardiovascular Disease West Fork Room

AOS.705.01F Optimizing Stem Cell Repair in Models of Disease Room C146

9:00-12:00 AOS.709.01N Sol Sherry Distinguished Lecture in Thrombosis and Treatment of Thrombotic Disease Room C140

AOS.725.01 Acute Coronary Syndrome Care and Complications: Quality Care and Outcomes Room C143

AOS.108.01 Cardiac MR Imaging I Clear Fork Room

AOS.201.01 Cholesterol Homeostasis: PCSK9 and Reverse Cholesterol Transport Room D163

9:00-5:00 APS.604.02 Aortic and Peripheral Vascular Disease; Pulmonary Embolism Hall F, Core 6

APS.715.02 Atherogenesis and Myocardial Injury Hall F, Core 7

BASC.03 Best of AHA Specialty Conferences: ATVB 2013 Hall F


APS.725.02 Chronic Coronary Artery Disease: Quality of Care and Outcomes Hall F, Core 7

APS.210.01 Diabetes Mellitus and CVD: Clinical Studies Hall F, Core 2

APS.211.05 Dyslipidemia and Treatment Hall F, Core 2

APS.202.01 Familial Hypercholesterolemia and Other Lipid Disorders Hall F, Core 2

APS.304.02 Genetic Variation and Coronary Artery Disease Hall F, Core 3



APS.212.11 Lipids and Multimarkers Hall F, Core 2


APS.202.02 New Insights into Lipoprotein Metabolism Hall F, Core 2

APS.703.02 Nitric Oxide and Endothelial Function Hall F, Core 7


APS.711.01 Redox Signaling and Oxidative Stress Hall F, Core 7




APS.705.03h Stem Cells and Tissue Engineering for Regeneration Hall F, Core 7



2:00-5:00 AOS.304.01F Common and Rare Variants Associated with CAD and Risk Factors Ballroom A2

AOS.202.01N George L. Duff Memorial Lecture and Therapeutic Approaches for Treating Dyslipidemias Room D167

AOS.108.02 Cardiac MR Imaging II West Fork Room

AOS.703.01 New Concepts in the Regulation of Vascular Endothelial Function Room C143

AOS.511.01 New Developments in Myocardial Pathology and Disease Hall B-9

AOS.727.01 Risk Factors Room C144

AOS.607.01 Thoracic Aortic Disease I Room D222

AOS.213.02 Treatment Decisions for Coronary Artery Disease: Quality of Care and Outcomes Room D163


AOS.606.01 Vulnerable Plaque, Drug-Eluting Stents: Insights from Advanced Coronary Imaging and Physiology Room D223

3:45-5:00 PS.04 Novel Oral Anticoagulants: Clinical Conundra Hall E

ATHEROSCLEROSIS AND THROMBOSIS (cont.)


TRACKS


Trac

ks

5:30-6:45 CVS.714 Inflammasomes and Cardiovascular Inflammation Room C150

CVS.212 Lowering ApoB-Containing Lipoproteins: Diversity of Therapeutic Targets Room D167

CVS.210 Racial/Ethnic Differences in Risks for Diabetes and Heart Disease: Implications for Diagnosis and Management

Room D163

Tuesday Nov 19

7:30-8:45 CVS.716 Crosstalk Between Oxidation and Inflammation in Vascular Disease Room C144

CVS.718 Incretin Hormones in CVD: New Kids on the Block Room C143

CVS.216 Lipid Metabolism in Cardiometabolic Syndrome and Atherogenesis Room D163

CVS.409 Management of Anticoagulation and Antiplatelet Agents at the Time of Device Procedure Hall B-3

CVS.717 Omega-3 Fatty Acids, Cardiovascular Health and Controversy Room C140

9:00-12:00 AOS.212.03N Ancel Keys Memorial Lecture and Subclinical Atherosclerosis and Cardiovascular Risk Room D167

AOS.106.01 CT Imaging of Coronary Atherosclerosis Clear Fork Room

AOS.405.01 Dilemmas in the Anticoagulation of Atrial Fibrillation Hall B-1

AOS.716.01N Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non– ST-Elevation ACS

Room C143

AOS.303.01 Multiscale Omics Reveals New Mechanisms of Cardiovascular Disease Ballroom A2

AOS.603.01 Novel Approaches and Technologies in AMI and Coronary Intervention Room D223

AOS.717.01 Optimizing Ways to Detect and Treat Ischemic Heart Disease Room C140

AOS.714.01 Peripheral Arterial Disease, Myopathy, Lipid and Cellular Modulation Room C144

9:00-5:00 APS.728.01 Biomarkers Hall F, Core 7

APS.202.04 Biomarkers, Lipoprotein Metabolism and CVD Hall F, Core 2



APS.304.03 Genetics of Lipids, Insulin Resistance and CAD Hall F, Core 3

APS.712.01 Growth Factors, Cytokines, Signal Transduction Hall F, Core 7

APS.707.01 Inflammation and Adhesion Molecules I Hall F, Core 7

APS.303.02 Insights from Omic Profiling of Cardiovascular Disease Hall F, Core 3






APS.511.01 New Insights into Myocardial Structure and Pathology Hall F, Core 5


APS.703.03 Novel Signaling Pathways in the Regulation of Endothelial Function Hall F, Core 7

APS.714.02 Peripheral Vascular Disease: Critical Limb Ischemia Hall F, Core 7



APS.202.03 Treatment of Dyslipidemias Hall F, Core 2

APS.212.10 Vascular Pathology and CVD Outcomes Hall F, Core 2


2:00-5:10 AOS.728.01 Cardiovascular Biomarkers Room C140

AOS.801.01 Case Studies: Finding a Needle in a Haystack Room D227



TRACKS


Tracks

5:30-6:45 ATE.702 Are Cholesterol-Loaded Macrophages Proinflammatory? Room C143

CVS.220 Dietary Management of Obesity and CVD Risk Factors: New Paradigms? Room D170

CVS.723 How Are Mechanisms of Arteriogenesis Affected by Metabolic Syndrome and Diabetes? Room C144

CVS.722 Lipid-Based Signaling Molecules and Their Receptors in Thrombosis and Vascular Biology Room C140

CVS.221 Mechanisms Regulating Hepatic VLDL Assembly and Secretion Room D163

Wednesday Nov 20

7:30-8:45 CVS.724 A2-Type Adenosine Receptors Revisited in Control of Metabolic and Vascular Disease Room C143

ATE.105 How to Image Vessel Wall and Atherosclerosis West Fork Room

CVS.525 Inflammation in Cardiac Disease and Remodeling Hall B-9

CVS.726 New Concepts in Arterial Stiffening and Hypertension Room C140

CVS.223 Obesity, Ectopic Fat and Cardiometabolic Risk: “It's Not How Much You Have But Where You Put It” Room D163

9:00-10:15 SS.15 The Legacy of Cardiovascular Disease for Cancer Survivors Room C147

9:00-12:00 APS.714.04 Aneurysmal Disease; Vasculopathies Hall F, Core 7

APS.611.01 Cellular Therapies for Heart Failure and Transplant Vasculopathy Hall F, Core 6

APS.104.02 Echocardiography and Coronary Artery Disease Hall F, Core 1



APS.707.02 Inflammation and Adhesion Molecules II Hall F, Core 7

APS.109.01 Noncoronary Vascular Imaging I Hall F, Core 1

APS.109.02 Noncoronary Vascular Imaging II Hall F, Core 1

APS.714.01 Peripheral Vascular Disease: Metabolic Disorders Hall F, Core 7

APS.703.04 Recent Advances in the Regulation of Vascular Endothelial Function Hall F, Core 7

APS.211.07 Subclinical CVD Imaging II Hall F, Core 2

9:00-12:10 AOS.701.01 Molecular Signals in Vascular Development and Disease Room C146

AOS.109.01 Noncoronary Vascular Imaging Clear Fork Room

AOS.604.01 Renovascular and Cerebrovascular Disease; Hypertension Room D223

AOS.707.01 Vascular Inflammation and Adhesion Receptors Room C144

CARDIAC STRUCTURE AND FUNCTIONSaturday Nov 16

1:00-2:40 EC.11 Mission Possible: Keys to Early Career Academic Success—Part 1 (Planned by the Council on Basic Cardiovascular Sciences)

Room C143


Room C143

Sunday Nov 17

8:00-11:00 SMP.401 Arrhythmogenic and Hypertrophic Cardiomyopathies: Scientific and Clinical Updates Hall B-4

SMP.503 Epigenetics of Cardiac Development and Disease Hall B-6

SMP.101 Myocardial Bioenergetics in Heart Failure West Fork Room

SMP.502 Stem Cell Therapeutics Hall B-5


SMP.501 The DeHaan Cardiac Myogenesis Initiative Room D223

9:00-5:00 APS.217.01 Cancer and Cardiovascular Disease I Hall F, Core 2

APS.514.05h Cardioprotection: Mechanisms of Ischemia-Reperfusion Injury Hall F, Core 5

APS.514.04 Cardioprotection: Translation and Clinical Implications Hall F, Core 5

APS.514.01 Cardioprotection: Focus on Mitochondria Hall F, Core 5



TRACKS


Trac

ks

9:00-5:00 APS.501.01 Cation Regulation Disorders and Heart Failure Hall F, Core 5

APS.502.02 Cell and Tissue Engineering Therapies for Heart Failure Hall F, Core 5

APS.501.03 Contractile Proteins and Key Signaling Molecules in Heart Failure Hall F, Core 5

APS.106.01 CT Imaging of Coronary Atherosclerosis I Hall F, Core 1

APS.210.03 Diabetes Mellitus and CVD: Basic Studies Hall F, Core 2

APS.101.02 Echocardiography in Diagnosis and Prognosis Hall F, Core 1

APS.101.01 Echocardiography: Right-Heart Function and Pressures Hall F, Core 1

APS.211.03 Epidemiology of Heart Failure Hall F, Core 2

APS.501.02 Extracellular Matrix Proteins and Cardiac Remodeling Hall F, Core 5

APS.519.04h Imaging and Outcomes in Valvular Heart Disease Hall F, Core 5

APS.101.04 Imaging Myocardial Mechanics Hall F, Core 1

APS.509.01 Metabolic Disorder and Cardiac Hypertrophy Hall F, Core 5


APS.518.04 Myopathic and Pericardial Disease: From Bench to Bedside Hall F, Core 5

APS.502.01 Novel Angiogenic and Regenerative Therapies for Heart Failure Hall F, Core 5

APS.209.03 Obesity in CVD Risk and Prevention: Basic Studies Hall F, Core 2

3:45-5:00 AOS.904.01Y Louis N. and Arnold M. Katz Basic Science Research Prize for Young Investigators Finalists Hall B-5

5:15-6:30 AOS.905.01Y Melvin L. Marcus Young Investigator Award in Cardiovascular Sciences Finalists Hall B-5

5:30-6:45 CVS.501 Cardiac Fibroblasts Hall B-6

CVS.502 Joint AHA/Progenitor Cell Biology Consortium Session: New Strategies for Myocardial Regeneration Clear Fork Room

CVS.102 Seamless Networks of Myocardial Bioenergetics West Fork Room

CVS.503 Systems Physiology of Cardiac Ischemia and Cell Death: New Molecular Regulators Room C147

Monday Nov 18

7:30-8:45 CVS.508 Molecular Signaling in Cardiac Development and Diseases Hall B-8

9:00-11:27 CS.01 Application of Cell-Based Therapies to Treat Cardiac and Peripheral Diseases Ballroom A1

9:00-12:00 AOS.101.01F Echocardiography of Ventricular Structure and Function Elm Fork Room

AOS.610.01N William W. L. Glenn Lecture and Surgical Therapy for Valvular Heart Disease II Room D227

9:00-12:10 AOS.108.01 Cardiac MR Imaging I Clear Fork Room

AOS.501.01 Cardiometabolic Mechanisms in Heart Failure Hall B-6

AOS.514.01 Cardioprotection: From Cellular Mechanisms to Ventricular Remodeling Hall B-8

AOS.605.01F New Developments in TAVR and Complex Structural Heart Interventions Room D223

9:00-5:00 APS.517.02h Biomarkers in Assessment of Changes in LV Function and Heart Failure: Role of Comorbidities, Filling Pressures and Heart Failure Status

Hall F, Core 5

APS.217.110 Cancer and Cardiovascular Disease II Hall F, Core 2

APS.302.01 Cardiac Development and Myocardial Regeneration Hall F, Core 3

APS.518.03 Clinical Aspects of Sarcoidosis and Various Cardiomyopathies Hall F, Core 5

APS.106.03 CT Imaging for Prognosis Hall F, Core 1

APS.108.01 Disease Prognosis by Cardiac MR Imaging I Hall F, Core 1

APS.108.02 Disease Prognosis by Cardiac MR Imaging II Hall F, Core 1

APS.102.04 Echocardiography: Clinical Applications of Myocardial Strain Imaging Hall F, Core 1

APS.102.02 Echocardiography: Contrast Imaging and Myocardial Function Hall F, Core 1

APS.102.03 Echocardiography: Right Ventricular Function and Mechanics Hall F, Core 1

APS.501.05 Gene Regulatory Mechanisms in Heart Failure Hall F, Core 5

APS.501.06 Immune and Inflammatory Mechanisms in Heart Failure Hall F, Core 5

APS.519.01 Molecular and Cellular Mechanisms of Valvular Heart Disease Hall F, Core 5

CARDIAC STRUCTURE AND FUNCTION (cont.)


TRACKS


Tracks

9:00-5:00 APS.509.02 Molecular Signaling in Cardiac Hypertrophy Hall F, Core 5

APS.513.02h Myocardial Energetics/Intermediary Metabolism I Hall F, Core 5

APS.107.01 Noncoronary CT Imaging Hall F, Core 1

APS.101.03 Novel Assessment of Diastolic Function Hall F, Core 1

APS.502.03 Novel Cellular Therapies for Ischemic Heart Failure Hall F, Core 5

APS.519.02 Pathophysiology and Patient Characteristics in Aortic Stenosis Hall F, Core 5

APS.211.06 Subclinical CVD Imaging I Hall F, Core 2

APS.212.01 Troponin, BNP and Other Biomarkers for CVD Risk Hall F, Core 2

BASC.05 Best of AHA Specialty Conferences: BCVS 2013 Hall F

12:40-1:40 SS.06 Lasker Awardee Lecture Hall E

2:00-5:10 AOS.517.01 How to Assess and Improve Left Ventricular Function and Heart Failure: From Left Ventricular Mechanics and Arterial Compliance to Biomarkers

Hall B-7

AOS.509.01 Molecular Basis of Hypertrophy Hall B-6


2:00-5:15 LBS.01F Late-Breaking Basic Science and Featured Research Presentation Hall B-5

5:00-7:00 LBS.02 Late-Breaking Basic Science Posters and Reception Hall F

APS.901.01 Best of Basic Science Abstracts and Reception Hall F

5:30-6:45 CVS.513 Cardiomyocyte Renewal Hall B-5

CVS.511 Dynamics of Protein Degradation Machinery in Cardiac Function Hall B-8

CVS.713 Emerging Paradigms in Progenitor Cell Therapy and Vascular Repair Room C143

CVS.714 Inflammasomes and Cardiovascular Inflammation Room C150

CVS.512 The Emerging Roles of Cardiac Secretome: From Discovery to Mechanisms Hall B-9

Tuesday Nov 19

7:30-8:45 CVS.516 Myofibrillar Proteins in Heart Failure Hall B-8

CVS.514 Novel Molecular Mechanisms of Mitochondrial Biology in the Heart Hall B-6

CVS.310 The Heart in the Muscular Dystrophies Ballroom A3

9:00-12:00 AOS.510.01N George E. Brown Memorial Lecture and Adult Stem Cells: Cardiac Homeostasis and Repair Hall B-7

9:00-12:10 AOS.501.02 Fibroblast Modulation in Cardiac Remodeling Hall B-6

AOS.512.01 Ventricular Function/Mechanics: Contractility and Biophysics Hall B-9

9:00-5:00 APS.516.01 Calcium, Mitochondrial Remodeling and Mitophagy Hall F, Core 5

APS.514.02 Cardioprotection: Remodeling, Heart Failure and Inflammation Hall F, Core 5

APS.207.04 Exercise, Physical Activity, Rehabilitation and CVD Risk I Hall F, Core 2

APS.207.05 Exercise, Physical Activity, Rehabilitation and CVD Risk II Hall F, Core 2

APS.518.01 Hypertrophic Cardiomyopathy Clinical Science Hall F, Core 5

APS.108.05 MR Characterization of Preclinical Disease Hall F, Core 1

APS.108.03 MR Imaging for Fibrosis and Arrhythmias Hall F, Core 1

APS.108.04 MR Imaging of Cardiac Structure Hall F, Core 1

APS.513.01 Myocardial Energetics/Intermediary Metabolism II Hall F, Core 5

APS.517.01 Novel Circulatory Biomarkers and Regulatory Proteins in Heart Failure Hall F, Core 5

APS.209.02 Obesity in CVD Risk and Prevention: From Children to Adults Hall F, Core 2

APS.518.02 Potpourri of Left Ventricular Function, Myocarditis and Pericarditis Hall F, Core 5

APS.713.01 Receptor Pharmacology Hall F, Core 7

APS.502.04 Tissue-Engineered and Cellular Therapies for Cardiomyopathy Hall F, Core 5

2:00-5:00 AOS.107.01N Charles T. Dotter Memorial Lecture and Noncoronary CT Topics Clear Fork Room

2:00-5:10 AOS.518.01 Hypertrophic Cardiomyopathy: Novel Treatment and Outcomes Hall B-9



TRACKS


Trac

ks

5:30-6:45 CVS.518 iPS Cells in Cardiac Disease Modeling Hall B-8

Wednesday Nov 20

7:30-8:45 CVS.523 Cardiac-Based Gene Therapies Hall B-5



CVS.728 Medical Management of Aneurysms: What Does the Evidence Show? Room C150

CVS.727 Rapid Nongenomic Mineralocorticoid Receptor Effects on Cardiovascular Function Room C146

CVS.524 Tissue Engineering Hall B-6

9:00-12:00 APS.514.03 Cardioprotection: Pre-, Peri-, and Postconditioning Hall F, Core 5

APS.700.123 Cardiorenal Physiology/Pathophysiology Part II Hall F, Core 7

APS.512.01 Ventricular Function/Mechanics Hall F, Core 5

9:00-12:10 AOS.519.01 Basic and Clinical Insights in Valvular Disease Hall B-7

AOS.212.02 Markers of Myocardial Injury/Stress and Cardiovascular Risk Room D163

AOS.513.01 Myocardial Energetics and Intermediary Metabolism in the Normal and Failing Heart Hall B-6

CARDIOPULMONARY RESUSCITATIONSaturday Nov 16

1:00-1:45 EC.08 Cardiac Electrophysiology Sessions for AHA Early Career Day—Part 1: Considering Electrophysiology as a Specialty

Room D227

Sunday Nov 17


8:00-11:00 SMP.402 Controversies in Hospital ECG Monitoring Hall B-3

SMP.703 Hypertensive Emergencies and Urgencies Room C150


3:45-5:00 AOS.400.01Y Cournand and Comroe Young Investigator Prize Finalists Hall B-1


5:30-6:45 CVS.503 Systems Physiology of Cardiac Ischemia and Cell Death: New Molecular Regulators Room C147

Monday Nov 18


ATE.402 Pro/Con: How Long Should We Continue Cardiac Arrest Resuscitation Efforts? Hall B-2

CVS.801 Strengthen the Chain: Improving Access to Acute Stroke Therapies Room D170

CVS.207 The Epidemic of Atrial Fibrillation: What's New for Non-EP Providers Room D168

9:00-12:10 AOS.408.01 Cardiac Arrest: Epidemiology and Clinical Outcomes Hall B-2

AOS.211.01 Fascinatin’ Rhythms: Epidemiology of Atrial Fibrillation and Sudden Death Room D170

9:00-5:00 APS.408.05 Cardiac Arrest and Resuscitation: Mechanisms and Laboratory Studies Hall F, Core 4

APS.408.04 Cardiac Arrest: Quality of Care and Educational Approaches Hall F, Core 4

2:00-3:15 CVS.405 Layperson and First Responder Approaches to Cardiac Arrest: Strengthening the Community Hall B-2

2:00-5:10 AOS.508.01 Disorders of Pulmonary Circulation: Bench to Bedside Hall B-8

3:45-5:00 AOS.400.02N Dickinson W. Richards Lecture and Abstracts Hall B-2

5:30-6:45 CVS.407 Impact of Medical Gases on Ischemia-Reperfusion and Cardiac Arrest Outcomes Hall B-2


CVS.214 Sudden Cardiac Death: State of the Science Room D170



TRACKS


Tracks

Tuesday Nov 19

7:30-8:45 CVS.215 Atrial Fibrillation: State of the Science Room D167

ATE.405 How to Improve Leadership and Teamwork in Resuscitation Hall B-2

CVS.410 Joint AHA/Society for Cardiovascular Pathology and Association for European Cardiovascular Pathology Session: Sudden Cardiac Death in the Young with Structurally Normal Heart

Hall B-1

9:00-5:00 APS.408.02 Cardiac Arrest and Resuscitation Innovations Hall F, Core 4

APS.408.03 Clinical Studies of Cardiac Arrest and Resuscitation Hall F, Core 4

APS.211.01 Epidemiology of Atrial Fibrillation and Sudden Cardiac Death Hall F, Core 2

2:00-3:15 CVS.412 Novel Strategies to Improve Outcome from Cardiac Arrest Hall B-3

3:45-5:00 CVS.219 Preparing Cardiac Patients and Families for End of Life Room D168

5:30-6:45 CVS.414 Practical Issues in Postarrest Therapeutic Hypothermia Hall B-2

CVS.415 Ventricular Fibrillation: From Bench to Bedside Hall B-4

Wednesday Nov 20

7:30-8:45 CVS.417 ECG Screening Programs for Prevention of Sudden Death: Benefits, Risks and Costs Hall B-3


CVS.416 Management of Atrial Fibrillation in Difficult Populations Hall B-1

ATE.506 Management of VAD Complications Hall B-7

9:00-10:15 CVS.812ic Screening Considerations for Athletes: Balancing the Risks with Cost of Assessment Ballrooms C3&C4

CARDIOVASCULAR AND STROKE NURSINGSaturday Nov 16

1:00-5:00 EC.05 Mechanisms and Models of Early Career Success in Cardiovascular and Stroke Nursing Science (Planned by the Council on Cardiovascular and Stroke Nursing)

Room D168

Sunday Nov 17

8:00-11:00 SMP.402 Controversies in Hospital ECG Monitoring Hall B-3

SMP.203 Nursing Science in Review: Top Trials in 2011-2013 Room D168

SMP.504 The Lost Souls of Heart Failure: Heart Failure with Preserved Ejection Fraction and Right-Heart Failure Hall B-8

SMP.304 Thrombosis, Antithrombotic Prophylaxis and Therapy in Pediatric Heart Disease Ballroom A1

9:00-5:00 APS.214.01 Cardiovascular Disease in Diverse Populations Hall F, Core 2

APS.204.01 Heart Disease in Children and Young Families Hall F, Core 2

APS.212.06 Lifestyle and Behavioral RFs Hall F, Core 2

3:45-5:00 AOS.200.01YN Katharine A. Lembright Award/Lecture and Martha N. Hill New Investigator Award Finalists Room D162


5:30-6:45 ATE.201 Achieving Accountability: How Will ACOs Impact the Delivery of Cardiovascular Care? Room D162

CVS.202 Is There Sex After Heart Disease? Room D168

CVS.301 New Therapies for Pediatric Heart Failure Ballroom A4

Monday Nov 18

7:30-8:45 CVS.205 Latest Nutrition Trials: Recent Progress and Shortcomings Room D167

ATE.503 Practical Issues in Heart Failure Readmissions: Stories from the Transition Trenches Hall B-9


CVS.305 Risk Management of Pregnancy in the Adult Congenital Heart Disease Patient Ballroom A1


CARDIOPULMONARY RESUSCITATION (cont.)


TRACKS


Trac

ks

9:00-10:15 ATE.202 Heart Tones/Brain Waves: The Body/Mind Connection Room D168

AOS.722.01N Stroke Council Award and Lecture and Prediction and Prognostication in Stroke: Clinical Aspects Room C144


AOS.211.01 Fascinatin’ Rhythms: Epidemiology of Atrial Fibrillation and Sudden Death Room D170

9:00-5:00 APS.404.04 Arrhythmia Management Hall F, Core 4

APS.404.05 Arrhythmia Mechanisms and Management Hall F, Core 4

APS.217.110 Cancer and Cardiovascular Disease II Hall F, Core 2

APS.204.02 Diagnostic Approaches in Heart Disease Hall F, Core 2

APS.205.03 Heart Failure Disease Management Hall F, Core 2

APS.722.01 Heart-Brain Interactions: Clinical Aspects Hall F, Core 7

10:45-12:00 AOS.205.01 Approaches to Disease and Self-Management Room D168

SS.04 Stopping the No. 1 Killer of Women in the Second Decade of Go Red For Women Ballrooms C1&C2

2:00-3:15 AOS.204.02 Symptoms and Symptom Management Room D168

3:45-5:00 CVS.209 Palliative Care and Congenital Heart Disease: Not Just at End of Life Room D168

5:30-6:45 CVS.610 Controversies in Heart Failure Surgery Room D222

CVS.307 Controversies in Postoperative Care Ballroom A4

CVS.509 Decision Making in Advanced Heart Failure Hall B-7


Room D163

CVS.211 State of Exercise Science for Cardiovascular Health Promotion: Methods, Measures and Interventions Room D168

7:00-9:00 CVES.03 Atrial Fibrillation Management: Clinical Challenges Omni Dallas Hotel, Dallas Ballroom BC

Tuesday Nov 19

7:30-8:45 ATE.405 How to Improve Leadership and Teamwork in Resuscitation Hall B-2

ATE.203 Symptom Recognition and CVD Room D168

9:00-10:15 CVS.218 Cognitive Dysfunction and Cardiovascular Disease: State of the Science Room D168

PS.05 Stroke Prevention in Atrial Fibrillation: New Options in 2013 Hall E

9:00-12:10 AOS.405.01 Dilemmas in the Anticoagulation of Atrial Fibrillation Hall B-1

AOS.404.02 Multidisciplinary Approaches to Arrhythmia Management Hall B-2

9:00-5:00 APS.211.04 Cardiovascular Implications of Noncardiac Medications Hall F, Core 2

APS.404.7987 Clinical Cardiac Electrophysiology III Hall F, Core 4

APS.205.01 Comorbidities in Cardiovasular Disease Hall F, Core 2

APS.205.02 Depression and Stress in Heart Disease Hall F, Core 2

10:45-12:00 AOS.204.01 Cognitive Function and Heart Failure Room D168

10:45-12:03 LBCT.05 New Strategies for Atrial Fibrillation Patients: Rhythm and Thrombosis Hall E

2:00-3:15 AOS.205.02 Strategies for Behavioral Change and Cardiovascular Risk Reduction Room D168

3:45-5:00 PS.07 Controversies in Heart Failure and the Answers Hall E

CVS.219 Preparing Cardiac Patients and Families for End of Life Room D168

3:45-5:13 CS.03 Novel Approaches to Treating Hypertension and Atherosclerosis Ballrooms C1&C2

5:30-6:45 ATE.205 Appropriately Implementing Appropriateness Use Criteria in Clinical Practice Room D162

ATE.206 Bringing Interventions to Diverse and Vulnerable Populations Room D168

CVS.414 Practical Issues in Postarrest Therapeutic Hypothermia Hall B-2

CARDIOVASCULAR AND STROKE NURSING (cont.)


TRACKS


Tracks

CARDIOVASCULAR AND STROKE NURSING (cont.)Wednesday Nov 20


CVS.615 Does It Make a Difference How You Think? Cardiovascular Disease and Cognition Room D222

ATE.207 Improving Patient Adherence to Treatment Recommendations Room D168

ATE.306 Infectious Diseases of the Heart: Updates on Old Problems Ballroom A1

CVS.317 The New Anticoagulants: Patient Education, Conversion, Management and Pharmacoeconomics— Is It Worth It?

Ballroom A2

9:00-10:25 AOS.205.200 Symptoms and Disease Management in Heart Failure Room D168

9:00-12:00 APS.205.04 Cardiovascular Disease: A Global Perspective Hall F, Core 2

APS.204.03 Cardiovascular Risk Hall F, Core 2

APS.404.3579 Clinical Cardiac Electrophysiology IV Hall F, Core 4

APS.405.02h Clinical Cardiac Electrophysiology V Hall F, Core 4

APS.407.01 What’s New in Pacing Hall F, Core 4

CARDIOVASCULAR STEM CELL BIOLOGY AND DEVELOPMENTSaturday Nov 16


Room C143


Room C143

Sunday Nov 17

8:00-11:00 SMP.503 Epigenetics of Cardiac Development and Disease Hall B-6

SMP.403 Joint AHA/Cardiac Electrophysiology Society Session: Atrial Fibrillation—Basic Mechanisms and Clinical Treatment in 2013

Hall B-1


SMP.507 The Best of Circulation Research Symposium Hall B-2

8:00-11:30 SMP.501 The DeHaan Cardiac Myogenesis Initiative Room D223

9:00-5:00 APS.510.05h Biology of Cardiac Regeneration Hall F, Core 5




APS.301.03h Molecular Regulation in Heart Failure Hall F, Core 3



APS.510.04 Progenitor Cells and Heart Development Hall F, Core 5


AOS.904.01Y Louis N. and Arnold M. Katz Basic Science Research Prize for Young Investigators Finalists Hall B-5


5:30-6:45 CVS.502 Joint AHA/Progenitor Cell Biology Consortium Session: New Strategies for Myocardial Regeneration Clear Fork Room


TRACKS


Trac

ks

Monday Nov 18

7:30-8:45 CVS.505 Cardiac Aging and DNA Damage Hall B-7


9:00-12:10 AOS.301.01 Epigenetic and Noncoding RNA Regulation in the Cardiovascular System Ballroom A2

9:00-5:00 APS.501.05 Gene Regulatory Mechanisms in Heart Failure Hall F, Core 5

APS.701.01 Regulators of Vascular Growth, Regeneration and Repair Hall F, Core 7

APS.510.01 Reprogramming: Cell Biology Is Going Backwards Hall F, Core 5



2:00-5:10 AOS.511.01 New Developments in Myocardial Pathology and Disease Hall B-9




5:30-6:45 CVS.513 Cardiomyocyte Renewal Hall B-5

CVS.713 Emerging Paradigms in Progenitor Cell Therapy and Vascular Repair Room C143

CVS.408 Novel Approaches to the Study of Arrhythmias Hall B-1


CVS.711 Vascular Stem Cells and Smooth Muscle Plasticity Room C140

Tuesday Nov 19

7:30-8:45 CVS.309 Epidemiology and Genetics of Adult Congenital Heart Disease: Insights from GenTAC, the National Registry of Genetically Triggered Aneurysms and Other Cardiovascular Conditions

Ballroom A4

CVS.411 Genetics, Mechanism and Therapy of Conduction Block Hall B-4

CVS.107 Imaging in Potential Novel Therapies for Cardiovascular Diseases West Fork Room

CVS.517 New Advances in Cardiac Systems Biology Hall B-7


9:00-12:10 AOS.502.01 Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure Hall B-5


9:00-5:00 APS.513.01 Myocardial Energetics/Intermediary Metabolism II Hall F, Core 5

APS.510.02 Myocardial Response to Injury Hall F, Core 5



2:00-5:10 AOS.302.01 Developmental and Reactive Cardiomyocyte Growth Signaling Ballroom A2

AOS.403.01 Molecular Mechanisms of Cardiac Arrhythmias Hall B-2

AOS.514.02 Novel Mechanisms of Cardioprotection and Stem Cell–Mediated Repair Hall B-6

5:30-6:45 CVS.723 How Are Mechanisms of Arteriogenesis Affected by Metabolic Syndrome and Diabetes? Room C144

CVS.518 iPS Cells in Cardiac Disease Modeling Hall B-8

CVS.109 Myocardial Repair West Fork Room

Wednesday Nov 20

7:30-8:45 CVS.523 Cardiac-Based Gene Therapies Hall B-5

9:00-12:00 APS.611.01 Cellular Therapies for Heart Failure and Transplant Vasculopathy Hall F, Core 6

APS.503.01 Novel Cellular Therapies for Heart Failure II Hall F, Core 5

APS.510.03 Novel Strategies in Cardiac Regeneration and Repair Hall F, Core 5

9:00-12:10 AOS.515.01 Mechanisms of Cardiomyocyte Death and Survival Hall B-8

AOS.701.01 Molecular Signals in Vascular Development and Disease Room C146

CARDIOVASCULAR STEM CELL BIOLOGY AND DEVELOPMENT (cont.)


TRACKS


Tracks

CONGENITAL HEART DEFECTS, CHILDREN AND HEALTH THROUGHOUT THE LIFE SPANSaturday Nov 16

1:00-3:00 EC.13 Choosing Your Path (Planned by the Council on Cardiovascular Disease in the Young) Room C144

Sunday Nov 17

8:00-11:00 SMP.204 Achieving the AHA’s 2020 Strategic Impact Goals Room D163

SMP.401 Arrhythmogenic and Hypertrophic Cardiomyopathies: Scientific and Clinical Updates Hall B-4

SMP.402 Controversies in Hospital ECG Monitoring Hall B-3

SMP.103 Intervention Imaging Elm Fork Room

SMP.303 New Genetic Tools in Congenital Heart Disease Ballroom A4


9:00-5:00 APS.305.04 Basic Studies and Basic Care in HLHS Hall F, Core 3

APS.216.04 Clinical and Hospital-Based Observational Studies Hall F, Core 2

APS.305.02 Congenital Heart Disease: Miscellaneous Aspects Hall F, Core 3

APS.211.08 Environment and Comorbid Conditions in CVD Hall F, Core 2


3:45-5:00 AOS.300.01Y CVDY Early Career Investigator Award Finalists Ballroom A1

5:30-6:45 ATE.401 Basic and Clinical Controversies in Brugada Syndrome Hall B-3

CVS.303 Genetics in Your Practice Ballroom A3


CVS.304 Open Questions in Interventional Cardiology Ballroom A1

Monday Nov 18

7:30-8:45 ATE.403 Early Repolarization in My Patient: Should I Be Concerned? Hall B-1


ATE.303 Septating the Unbalanced Heart: Should We or Shouldn’t We? Ballroom A4

9:00-10:28 LBCT.02 Prevention: From Schools to Countries Ballrooms C1&C2


9:00-12:10 AOS.309.01 Adult Congenital Heart Disease: Morbidity and Mortality with and Without Intervention Ballroom A3

AOS.308.01 Single-Ventricle Surgery: From Start to Fontan Ballroom A4

9:00-5:00 APS.102.03 Echocardiography: Right Ventricular Function and Mechanics Hall F, Core 1

APS.305.01 Pediatric Electrophysiology: Tachycardias, Pacing and Ablation Hall F, Core 3

APS.310.01 Pediatric Heart Failure Hall F, Core 3

APS.306.01 Pediatric Imaging: Ventricular Volume, Mass and Function Hall F, Core 3

10:45-12:00 SS.05 Contemporary Assessment of the Right Heart Room C147

2:00-3:15 SS.08 Success Story and Growing Challenge: Adult Congenital Heart Disease Ballrooms C3&C4

2:00-5:00 AOS.102.01F 3D Echocardiography of Heart Valve Anatomy and Intracardiac Flow Clear Fork Room

2:00-5:10 AOS.511.01 New Developments in Myocardial Pathology and Disease Hall B-9

AOS.308.02 Pediatric Heart Surgery: Perioperative Issues and Late Outcomes Ballroom A1

AOS.307.01 Tachycardia: Basic and Applied; Lipids and Hypertension Ballroom A4

3:45-5:00 CVS.209 Palliative Care and Congenital Heart Disease: Not Just at End of Life Room D168

5:30-6:45 CVS.307 Controversies in Postoperative Care Ballroom A4

ATE.304 Improving ACHD Care Delivery Ballroom A1



TRACKS


Trac

ks

Tuesday Nov 19


Ballroom A4

CVS.515 Heart Failure in the Patient with Adult Congenital Disease Hall B-9


Hall B-1

ATE.305 Risk Factor Control in Patients with Congenital Heart Disease Ballroom A1

7:30-8:45 CVS.310 The Heart in the Muscular Dystrophies Ballroom A3

9:00-11:00 MOC.03 Maintenance of Certification: Part 2 Credit Using the American Board of Pediatrics 2013 Pediatric Cardiology Subspecialty Self-Assessment

Room C155

9:00-12:10 AOS.305.05 Free Pulmonary Insufficiency and Other Daily Problems Ballroom A1

AOS.310.01 Pediatric Heart Failure: Prognosis and Treatment from Infusion to Transplant Ballroom A4


9:00-5:00 APS.102.05 3D/4D Echocardiography Hall F, Core 1

APS.308.02 Pediatric Cardiac Surgery: Peri- and Postoperative Issues Hall F, Core 3

APS.305.03 Pediatric Hypertension and Lipids; Late Implications of Adult Congenital Heart Disease Hall F, Core 3

10:45-12:00 SS.18 Joint AHA/NEJM Session: Clinical Decisions—Should Young Athletes Undergo Pre-Participation Cardiovascular Screening?

Room C147

2:00-5:00 AOS.305.01N T. Duckett Jones Memorial Lecture, Best of CVDY and Aspects of Acquired Disease Ballroom A1

5:30-6:45 CVS.312 Familial Hypercholesterolemia: Challenges and Opportunities Ballroom A2

CVS.314 Hypoplastic Left-Heart Syndrome: How Far Have We Come? Ballroom A1

CVS.315 Technical Innovations in Pediatric Electrophysiology Ballroom A4

Wednesday Nov 20

7:30-8:45 CVS.318 Challenging Imaging Diagnoses: What Tools Are Available? Ballroom A4

CVS.417 ECG Screening Programs for Prevention of Sudden Death: Benefits, Risks and Costs Hall B-3


CVS.616 PAD in Younger Patients (<40 Years of Age): Special Considerations Room D227

CVS.316 Pathogenesis of Autoimmune-Associated Heart Abnormalities: From Bench to Bedside Ballroom A3

9:00-12:00 APS.309.01 Adult Congenital Heart Disease: Outcomes Hall F, Core 3

APS.309.02h Adult Congenital Heart Disease: Predictors of Outcome and Implications of Fontan Hall F, Core 3

9:00-12:10 AOS.516.01 Autophagy, Mitochondria and Protein Homeostasis Hall B-5

AOS.701.01 Molecular Signals in Vascular Development and Disease Room C146

AOS.306.01 Pediatric Imaging: Function and Flow Ballroom A4

AOS.311.01 Single-Ventricle Cardiology: Palliation, Care and Resource Utilization Ballroom A3

DIABETES, LIPIDS AND CARDIOMETABOLIC SYNDROMESaturday Nov 16

7:00-9:00 CVES.01 Diabetes and Cardiovascular Disease: Current Controversies Omni Dallas Hotel, Dallas Ballroom BC

Sunday Nov 17

8:00-11:00 SMP.205 Clinical Lipidology: Controversies in Cardiovascular Risk Reduction Room D167




SMP.301 Personalized Medicine: Pharmacogenomics and Metabolomics—Is That Your Final Answer? Ballroom A3

SMP.701 The Inflammasome Pathway in Cardiovascular and Metabolic Disease—Basic Science to Clinical Trials Room C144

CONGENITAL HEART DEFECTS, CHILDREN AND HEALTH THROUGHOUT THE LIFE SPAN (cont.)


TRACKS


Tracks

9:00-5:00 APS.514.05h Cardioprotection: Mechanisms of Ischemia-Reperfusion Injury Hall F, Core 5






APS.207.03 Exercise/Physical Activity: Basic Aspects Hall F, Core 2

APS.212.07 Hormonal and Systemic Risk Factors Hall F, Core 2


APS.201.01 Mechanisms and Regulation of Hepatic Lipid Metabolism Hall F, Core 2


APS.789.967 Predictors of Cardiorenal Risk Hall F, Core 7

APS.516.02h Regulation of Autophagy and Protein Homeostasis Hall F, Core 5




APS.201.02 Targeted Modulation of Lipid Metabolism Hall F, Core 2


CVS.801ic Stemming the Tide: The Role of Physical Activity in Reversing the Obesity and Diabetes Epidemic Ballrooms C3&C4

5:30-6:45 CVS.203 Brown Adipose Tissue: Its Renaissance and Relevance to Cardiovascular Health Room D163

CVS.201 How Should We Conduct Cardiovascular Disease Trials? Room D170




Monday Nov 18

7:30-8:45 CVS.205 Latest Nutrition Trials: Recent Progress and Shortcomings Room D167

CVS.206 Pathway-Selective Insulin Resistance and Cardiovascular Complications: How High Levels of Insulin Can Cause Harm

Room D163




AOS.201.01 Cholesterol Homeostasis: PCSK9 and Reverse Cholesterol Transport Room D163

9:00-5:00 APS.718.01 Cardiorenal Physiology/Pathophysiology I Hall F, Core 7


APS.202.01 Familial Hypercholesterolemia and Other Lipid Disorders Hall F, Core 2



APS.720.02 Hypertension: Clinical—Blood Vessels, Aldosterone and Blood Pressure Hall F, Core 7

APS.209.04h Impact of Obesity on Cardiac Structure and Function Hall F, Core 2



APS.202.02 New Insights into Lipoprotein Metabolism Hall F, Core 2



APS.206.01 Nutrition in CVD Risk and Prevention Hall F, Core 2


DIABETES, LIPIDS AND CARDIOMETABOLIC SYNDROME (cont.)


TRACKS


Trac

ks

9:00-5:00 APS.702.06h Risk Factors and Systemic Mediators of Atherosclerosis Hall F, Core 7




10:45-12:13 LBCT.03 Medical and Surgical Approaches to Improving Heart Failure Outcomes Hall E

2:00-3:15 PS.03ic Solving the Obesity/Type 2 Diabetes Epidemic: The Role of Physical Activity/Exercise Hall E


AOS.202.01N George L. Duff Memorial Lecture and Therapeutic Approaches for Treating Dyslipidemias Room D167

2:00-5:10 AOS.703.01 New Concepts in the Regulation of Vascular Endothelial Function Room C143



5:30-6:45 CVS.714 Inflammasomes and Cardiovascular Inflammation Room C150



Room D163


Tuesday Nov 19

7:15-8:43 CS.02 Biomarkers in Populations Ballrooms C1&C2

CVS.716 Crosstalk Between Oxidation and Inflammation in Vascular Disease Room C144


CVS.217 Joint AHA/Asia Pacific Society of Cardiology Session: Noncommunicable Diseases— East Versus West

Room D170



9:00-10:15 SS.10 Diabetes and Heart Failure: The Joint Epidemics Ballrooms C1&C2

9:00-12:10 AOS.210.01 Diabetes Mellitus and CVD: Prevention and Management Room D170




9:00-5:00 APS.202.04 Biomarkers, Lipoprotein Metabolism and CVD Hall F, Core 2


APS.216.02 Clinical and Hospital-Based Observational Studies: CVD Risk Factors Hall F, Core 2





APS.712.01 Growth Factors, Cytokines, Signal Transduction Hall F, Core 7







TRACKS


Tracks

9:00-5:00 APS.706.02 Novel Mechanisms and Therapeutics in Angiogenesis Part II Hall F, Core 7



APS.209.01 Obesity-Associated Comorbidities Hall F, Core 2




12:30-1:30 SS.12 Distinguished Scientist Lecture Ballrooms C1&C2


AOS.702.01N Russell Ross Memorial Lectureship in Vascular Biology and Mechanisms of Atherosclerosis Room C143

AOS.708.01F Translational Insights in the Regulation of Vascular Resistance in Health and Disease Room C146


AOS.209.01 Obesity and CVD: Beyond Body Weight Room D170



CVS.222 Debate: Can We Agree on Approaches to Risk Assessment? Room D167


CVS.312 Familial Hypercholesterolemia: Challenges and Opportunities Ballroom A2



CVS.221 Mechanisms Regulating Hepatic VLDL Assembly and Secretion Room D163

Wednesday Nov 20










APS.515.01h Mechanisms of Cell Death and Translational Implications Hall F, Core 5






AOS.515.01 Mechanisms of Cardiomyocyte Death and Survival Hall B-8


AOS.208.01 Novel Insights from Clinical Trials and Preventive Interventions Room D170




TRACKS


Trac

ks

EARLY CAREER/PROFESSIONAL DEVELOPMENTSaturday Nov 16

8:00-5:20 EC.21 Peripheral Vascular Disease—Fellows in Training Workshop Ballroom A1

9:00-10:00 EC.02 Opening General Session (Part 1) Ballrooms C1&C2

10:00-11:45 EC.03 Opening General Session (Part 2—New Paradigms and Opportunities in Cardiovascular Research for Clinical and Basic Science Researchers

Ballrooms C1&C2


Room D227

1:00-2:00 EC.12 How to Thrive as an Early Career Academic Cardiovascular Specialist (Planned by the Council on Clinical Cardiology)

Room C140

1:00-2:30 EC.07 Challenges at the Start of Your Cardiac Surgical Practice (Planned by the Council on Cardiovascular Surgery and Anesthesia)

Room C150


Room C143

1:00-2:45 EC.04 Training and Funding: How to Get Started as an Early Career Investigator (Planned by the Quality of Care and Outcomes Research/Epidemiology and Prevention/Lifestyle and Cardiometabolic Health Councils)

Room D223

1:00-3:00 EC.13 Choosing Your Path (Planned by the Council on Cardiovascular Disease in the Young) Room C144

EC.06 How to Build a Road Map for Your Career in Functional Genomics and Translational Biology (Planned by the Council on Functional Genomics and Translational Biology)

Room D163

1:00-5:00 EC.10 Cardiac Imaging Boot Camp (Planned by the Council on Cardiovascular Radiology and Intervention) Room D170

EC.09 Interventional Cardiology Fellows Program Room D226

EC.05 Mechanisms and Models of Early Career Success in Cardiovascular and Stroke Nursing Science (Planned by the Council on Cardiovascular and Stroke Nursing)

Room D168

1:45-3:00 EC.14 Cardiac Electrophysiology Sessions for AHA Early Career Day—Part 2: My Story—A Panel Discussion on the Different Types of EP Career Options

Room D227

3:00-4:20 EC.17 How to Develop a Successful Research Career (Planned by the Epidemiology and Prevention/Lifestyle and Cardiometabolic Health Councils)

Room D223


Room C143

3:00-5:00 EC.18 Hottest of the Hot in FGTB Research (Planned by the Council on Functional Genomics and Translational Biology)

Room D163

EC.15 Starting a Successful Career in Quality of Care and Outcomes Research (Planned by the Council on Quality of Care and Outcomes Research)

Room D222

3:15-5:00 EC.19 Cardiac Electrophysiology Sessions for AHA Early Career Day—Part 3: Early Career EP Clinical Session Room D227

Sunday Nov 17



Hall B-1

5:30-6:45 CVS.402 Controversies and Updates in Lead Management Hall B-1

CVS.403 Subcellular Structures as Arrhythmia Substrates Hall B-2

Monday Nov 18

9:00-11:30 MOC.01 Maintenance of Certification: ABIM Learning Session—Cardiovascular Disease 2013 Update (A1-P) Room C155

9:00-5:00 APS.406.04 Catheter Ablation of Atrial Fibrillation Hall F, Core 4

2:00-4:30 MOC.02 Maintenance of Certification: ABIM Learning Session—Interventional Cardiology 2013 Update (B2-P) Room C155

5:30-6:45 CVS.406 Arrhythmias in “Normal” Hearts: Evaluation and Management in 2013 Hall B-4



TRACKS


Tracks

EARLY CAREER/PROFESSIONAL DEVELOPMENT (cont.)Tuesday Nov 19

9:00-11:00 MOC.03 Maintenance of Certification: Part 2 Credit Using the American Board of Pediatrics 2013 Pediatric Cardiology Subspecialty Self-Assessment

Room C155

9:00-5:00 APS.511.01 New Insights into Myocardial Structure and Pathology Hall F, Core 5

2:00-4:30 MOC.04 Maintenance of Certification: ABIM Learning Session—Clinical Cardiac Electrophysiology 2013 Update (B3-P)

Room C155

2:00-5:10 AOS.406.01 Techniques/Technologies to Improve AF Ablation Hall B-1

Wednesday Nov 20

9:00-12:00 APS.406.01 Ablation Therapy for Ventricular Tachycardia Hall F, Core 4

ELECTROPHYSIOLOGYSaturday Nov 16


Room D227

1:45-3:00 EC.14 Cardiac Electrophysiology Sessions for AHA Early Career Day—Part 2: My Story—A Panel Discussion on the Different Types of EP Career Options

Room D227

3:15-5:00 EC.19 Cardiac Electrophysiology Sessions for AHA Early Career Day—Part 3: Early Career EP Clinical Session

Room D227

Sunday Nov 17






Hall B-1


APS.216.03 Clinical and Hospital-Based Observational Studies: Congestive Heart Failure, Atrial Fibrillation and Cardiac Surgery

Hall F, Core 2

APS.404.01 Clinical Management of Atrial Fibrillation I Hall F, Core 4

APS.404.02 Clinical Management of Atrial Fibrillation II Hall F, Core 4

APS.407.02 Device Implantation and Extraction Hall F, Core 4

APS.213.03 Heart Failure and Electrophysiology Quality of Care and Outcomes Hall F, Core 2

APS.505.01 Heart Failure: CRT, Pacing, Sleep Apnea and Outcomes Hall F, Core 5

APS.401.01 Mechanisms Regulating Ion Channel Expression and Trafficking Hall F, Core 4

APS.404.03 Resynchronization Therapy and Arrhythmias Hall F, Core 4

APS.403.23 Sinus Node Dysfunction and Atrial Arrhythmias Hall F, Core 4


CVS.401 Beyond Point-by-Point PVI: New Interventional Approaches to AF Ablation Hall B-4

CVS.402 Controversies and Updates in Lead Management Hall B-1


Monday Nov 18

7:30-8:45 CVS.506 Arrhythmias Complicating Heart Failure Hall B-6

ATE.403 Early Repolarization in My Patient: Should I Be Concerned? Hall B-1

ATE.102 Image-Guided Therapy West Fork Room

CVS.404 Management of Frequent Ventricular Ectopy Hall B-4

ATE.404 New Developments in Mechanism and Treatment of Inherited Channelopathies Hall B-3


TRACKS


Trac

ks

9:00-10:15 SS.03 Joint AHA/European Society of Cardiology Session: Personalized Medicine—The Future of Atrial Fibrillation Management

Room C147


AOS.402.01N Thomas Smith Memorial Lecture and Subcellular Calcium Control and Arrhythmias Hall B-1

9:00-12:10 AOS.211.01 Fascinatin’ Rhythms: Epidemiology of Atrial Fibrillation and Sudden Death Room D170

AOS.505.01 Heart Failure: Pacing, Outcomes and Future Device Interventions Hall B-7

9:00-5:00 APS.404.04 Arrhythmia Management Hall F, Core 4

APS.404.05 Arrhythmia Mechanisms and Management Hall F, Core 4

APS.403.03 Cardiac Repolarization and Ventricular Arrhythmias Hall F, Core 4

APS.406.04 Catheter Ablation of Atrial Fibrillation Hall F, Core 4

APS.207.02 Clinical Aspects of Exercise, Physical Activity and Rehabilitation Hall F, Core 2

APS.204.02 Diagnostic Approaches in Heart Disease Hall F, Core 2

APS.505.02 Heart Failure: Pacing and Other Therapeutic Devices Hall F, Core 5

APS.404.06 Heart Rhythm Disorders: Clinical Features Hall F, Core 4



APS.401.02 Mechanisms of Bradyarrhythmias and Tachyarrhythmias Hall F, Core 4

APS.406.02 Novel Technologies for AF Ablation Hall F, Core 4

APS.305.01 Pediatric Electrophysiology: Tachycardias, Pacing and Ablation Hall F, Core 3

APS.725.03 Percutaneous Coronary Interventions: Quality of Care and Outcomes Hall F, Core 7

APS.406.03 Prediction of Outcome for AF Ablation Hall F, Core 4

APS.406.07 Strategies and Techniques for Atrial Fibrillation Ablation Hall F, Core 4


2:00-2:45 CT.03 Learning at the Movies: Surgical Tribulations of a Heart Failure Patient: VAD + Transplant Hall F, Case Theater

2:00-3:15 SS.07 Best of Other Cardiovascular Meetings (Domestic) Room C147

2:00-5:00 AOS.401.01F Calmodulin and Arrhythmias Hall B-4

2:00-5:10 AOS.406.02 Complications of Ablation for Atrial Fibrillation Hall B-1


3:00-3:45 CT.04 Learning at the Movies: VT Ablation—State of the Art 2013 Hall F, Case Theater

5:30-6:45 CVS.406 Arrhythmias in “Normal” Hearts: Evaluation and Management in 2013 Hall B-4

CVS.306 Bystander or Player? SCN10A in Cardiac Conduction Ballroom A2




Tuesday Nov 19


CVS.411 Genetics, Mechanism and Therapy of Conduction Block Hall B-4


Hall B-1


9:00-10:15 PS.05 Stroke Prevention in Atrial Fibrillation: New Options in 2013 Hall E

ELECTROPHYSIOLOGY (cont.)


TRACKS


Tracks

9:00-12:10 AOS.405.01 Dilemmas in the Anticoagulation of Atrial Fibrillation Hall B-1



AOS.611.01 Surgical Therapy for Atrial Fibrillation and End-Stage Heart Failure Room D227


APS.724.01 Autonomic Control and Regulation Hall F, Core 7

APS.403.04 Cellular/Molecular Mechanisms of Atrial Fibrillation Hall F, Core 4

APS.400.0923 Clinical Cardiac Electrophysiology I Hall F, Core 4

APS.404.07 Clinical Cardiac Electrophysiology II Hall F, Core 4

APS.404.7987 Clinical Cardiac Electrophysiology III Hall F, Core 4

APS.404.08 Clinical Electrophysiology, Diagnosis and Risk Stratification Hall F, Core 4


APS.212.13 ECG Markers of CVD Risk Hall F, Core 2

APS.104.01 Echocardiographic Imaging of the Right Heart and in Arrhythmias Hall F, Core 1

APS.211.01 Epidemiology of Atrial Fibrillation and Sudden Cardiac Death Hall F, Core 2



APS.304.01 Genetics of CVD: From Drug Response to Biomarkers and Outcomes Hall F, Core 3

APS.407.03 Implantable Cardioverter-Defibrillators: Outcomes and Utilization Hall F, Core 4



APS.405.01 Pharmacological Treatment of Atrial Fibrillation Hall F, Core 4

APS.402.02 Sarcolemmal Ion Channels and Arrhythmias Hall F, Core 4

APS.402.01 Stem Cell–Derived Cardiomyocyte Models of Arrhythmia Hall F, Core 4


Room C147

2:00-3:15 SS.14 Enhancing Response to Resynchronization Therapy Ballrooms C1&C2

SS.13 Sudden Cardiac Death: From Pathology to Population Room C147

2:00-4:30 MOC.04 Maintenance of Certification: ABIM Learning Session—Clinical Cardiac Electrophysiology 2013 Update (B3-P)

Room C155

2:00-5:10 AOS.801.01 Case Studies: Finding a Needle in a Haystack Room D227


AOS.216.01 Novel Insights into CVD Treatments and Outcomes from Observational Studies Room D163

AOS.406.01 Techniques/Technologies to Improve AF Ablation Hall B-1

5:30-6:45 CVS.319 Contemporary Challenges in Drug Safety in an Era of Personalized Medicine Hall B-3


CVS.315 Technical Innovations in Pediatric Electrophysiology Ballroom A4

CVS.413 Update in Ventricular Tachycardia Ablation Hall B-1


Wednesday Nov 20


ATE.406 Joint AHA/American Autonomic Society Session: Orthostatic Hypotension—An Emerging Epidemic Hall B-2



CVS.316 Pathogenesis of Autoimmune-Associated Heart Abnormalities: From Bench to Bedside Ballroom A3

ATE.407 Successful Approach to Fainting and Dizziness Hall B-4



TRACKS


Trac

ks

9:00-12:00 APS.406.01 Ablation Therapy for Ventricular Tachycardia Hall F, Core 4


APS.406.05 Catheter Ablation of Atrial Tachycardia and Atrial Flutter Hall F, Core 4

APS.404.3579 Clinical Cardiac Electrophysiology IV Hall F, Core 4

APS.405.02h Clinical Cardiac Electrophysiology V Hall F, Core 4

APS.403.01 Experimental Models of Cardiac Arrhythmias Hall F, Core 4


APS.406.06 Impact of Ablation for Atrial Fibrillation Hall F, Core 4

APS.407.01 What’s New in Pacing Hall F, Core 4

AOS.407.01 Implantable Cardioverter-Defibrillators: Management Issues and Therapy Hall B-1

AOS.404.01 Mechanistic Insights into Clinical Arrhythmias Hall B-2

AOS.724.01 Neurohormonal Regulation and Cardiovascular Control Room C143


GENERAL CARDIOLOGY AND STRUCTURAL HEART DISEASESaturday Nov 16

1:00-2:00 EC.12 How to Thrive as an Early Career Academic Cardiovascular Specialist (Planned by the Council on Clinical Cardiology)

Room C140

2:15-3:30 AOS.901.01Y Samuel A. Levine Young Clinical Investigator Award Finalists Room C140

3:45-5:00 AOS.902.01Y Laennec Young Clinician Award Finalists Room C140


Sunday Nov 17

8:00-11:00 SMP.505 Acute Heart Failure: A New Era or Same Old Problems? Hall B-7

SMP.401 Arrhythmogenic and Hypertrophic Cardiomyopathies: Scientific and Clinical Updates Hall B-4

SMP.205 Clinical Lipidology: Controversies in Cardiovascular Risk Reduction Room D167



SMP.102 Imaging Cardiomyopathy Clear Fork Room




8:00-11:00 SMP.403 Joint AHA/Cardiac Electrophysiology Society Session: Atrial Fibrillation—Basic Mechanisms and Clinical Treatment in 2013

Hall B-1






9:00-5:00 APS.217.01 Cancer and Cardiovascular Disease I Hall F, Core 2








TRACKS


Tracks

9:00-5:00 APS.101.01 Echocardiography: Right-Heart Function and Pressures Hall F, Core 1







APS.503.03 Molecular Markers of Heart Failure Hall F, Core 5








3:00-3:45 CT.01 Learning at the Movies: Closing a Perivalvular Leak Hall F, Case Theater

3:45-5:00 SS.02 Joint AHA/ACC Session: ACCF/AHA Guidelines for Management of Chronic Heart Failure: 2013 Update Ballrooms C1&C2

CVS.801ic Stemming the Tide: The Role of Physical Activity in Reversing the Obesity and Diabetes Epidemic Ballrooms C3&C4


CVS.402 Controversies and Updates in Lead Management Hall B-1

CVS.303 Genetics in Your Practice Ballroom A3

CVS.504 Hypertrophic Cardiomyopathy and Athlete’s Heart Hall B-8

CVS.202 Is There Sex After Heart Disease? Room D168

ATE.501 Joint AHA/Heart Failure Society of America Session: Chemotherapy and Cardiomyopathy Hall B-7


CVS.602 New Considerations in Destination VAD Therapy Room D223

CVS.101 State of the Art in Cardiac Computed Tomography Elm Fork Room

7:00-9:00 CVES.02 Heart Failure: Challenges Old and New Omni Dallas Hotel, Dallas Ballroom BC

Monday Nov 18


CVS.709 Challenges in Acute and Chronic Thromboembolic Disease Room C140

ATE.302 Common Variants and Clinical Risk: dbSNP Versus dbBS Ballroom A2

ATE.403 Early Repolarization in My Patient: Should I Be Concerned? Hall B-1

ATE.102 Image-Guided Therapy West Fork Room

CVS.103 Imaging for Viability: Is It Viable? Elm Fork Room

CVS.205 Latest Nutrition Trials: Recent Progress and Shortcomings Room D167


CVS.507 Mechanical Options in Acutely Decompensated Heart Failure Hall B-5

CVS.603 PCI and Atrial Fibrillation: The Triple Therapy Dilemma Room D227



ATE.101 Taking the Load Off Imaging Diastolic Function Clear Fork Room


GENERAL CARDIOLOGY AND STRUCTURAL HEART DISEASE (cont.)


TRACKS


Trac

ks

7:30-8:45 CVS.708 Thoracic Aortic Disease: Etiology, Pathology, Imaging and Care Room C144

ATE.603 Update on Aortic Valve Repair Room D222


PS.01 Heart Valve Disease: State of the Science and Controversies Hall E

SS.03 Joint AHA/European Society of Cardiology Session: Personalized Medicine—The Future of Atrial Fibrillation Management

Room C147

9:00-11:30 MOC.01 Maintenance of Certification: ABIM Learning Session—Cardiovascular Disease 2013 Update (A1-P) Room C155





AOS.309.01 Adult Congenital Heart Disease: Morbidity and Mortality with and Without Intervention Ballroom A3

9:00-5:00 APS.217.110 Cancer and Cardiovascular Disease II Hall F, Core 2






APS.102.01 Echocardiography: Myocardial Function and Strain Hall F, Core 1







APS.519.03 Outcomes in Aortic Stenosis Hall F, Core 5


APS.212.09 Risk Prediction for CVD and HIV-CVD Hall F, Core 2







2:00-3:15 PS.02 Joint AHA/American Society of Echocardiography Session: Imaging Preclinical Cardiovascular Disease Ballrooms C1&C2

SS.08 Success Story and Growing Challenge: Adult Congenital Heart Disease Ballrooms C3&C4


AOS.104.01F Stress Echocardiography: New Insights Elm Fork Room

2:00-5:10 AOS.215.01 Reaching the AHA 2020 Goals: Strategies for Success Room D162



CVS.209 Palliative Care and Congenital Heart Disease: Not Just at End of Life Room D168

SS.19 Data Sharing in Research: Challenges and Opportunities Room C147



TRACKS


Tracks

5:30-6:45 CVS.106 Advances in Echocardiography Clear Fork Room

CVS.406 Arrhythmias in “Normal” Hearts: Evaluation and Management in 2013 Hall B-4

CVS.104 Cardiac MRI 2013: Putting Your Best Spin on It Elm Fork Room

CVS.308 Circulation Cardiovascular Genetics/Functional Genomics and Translational Biology Ballroom A3

CVS.610 Controversies in Heart Failure Surgery Room D222


CVS.510 Heart Rate Reduction as a Therapeutic Target in Heart Failure Hall B-6

CVS.226 HIV: A New Paradigm for Cardiovascular Disease Hall B-3

ATE.304 Improving ACHD Care Delivery Ballroom A1


CVS.611 Minimally Invasive Cardiac Surgery: Where Are We in 2013? Room D223

CVS.105 Multimodality Imaging of Peripheral Arterial Disease West Fork Room

CVS.710 New Insights into the Medical Management of Intermittent Claudication: A Mechanistic Perspective on Current and Emerging Therapies

Room C144


Room D163




Tuesday Nov 19


ATE.103 Challenges in Imaging Aortic Valve Disease Clear Fork Room

ATE.504 Controversies and Challenges in Heart Failure Pharmacotherapy Hall B-5

ATE.607 Controversies in Mitral Valve Repair for Degenerative Disease Room D222


CVS.108 In Search of the Culprit Lesion: Utility of Imaging Elm Fork Room

ATE.606 Managing Bleeding in Anticoagulated Patients: New Oral Anticoagulants and New Issues Room D223


ATE.203 Symptom Recognition and CVD Room D168


9:00-9:45 CT.05 Learning at the Movies: Lessons from a TAVR Case Hall F, Case Theater


SS.10 Diabetes and Heart Failure: The Joint Epidemics Ballrooms C1&C2



9:00-12:10 AOS.102.02 Clinical Applications of Advanced Echocardiographic Imaging Elm Fork Room


AOS.210.01 Diabetes Mellitus and CVD: Prevention and Management Room D170


AOS.305.05 Free Pulmonary Insufficiency and Other Daily Problems Ballroom A1


Room C143




TRACKS


Trac

ks

9:00-5:00 APS.211.04 Cardiovascular Implications of Noncardiac Medications Hall F, Core 2

APS.212.12 Chronic Kidney Disease and CVD Hall F, Core 2

APS.404.07 Clinical Cardiac Electrophysiology II Hall F, Core 4

APS.212.08 Demographic and Physiological RFs Hall F, Core 2

APS.212.13 ECG Markers of CVD Risk Hall F, Core 2


APS.103.01 Echocardiography for the Evaluation and Treatment of Structural Heart Disease Hall F, Core 1

APS.102.06 Echocardiography: 2D/3D Echo, Multimodality/Fusion Imaging Hall F, Core 1

APS.720.03 Hypertension: Clinical—Drug Treatment, Measurement and Blood Pressure Hall F, Core 7




APS.108.06 MR Imaging in Clinical Syndromes Hall F, Core 1



APS.723.03 Pulmonary Hypertension: Novel Imaging Techniques Hall F, Core 7

10:00-10:45 CT.06 Learning at the Movies: Management of Hypertrophic Obstructive Cardiomyopathy— A Heart Team Approach

Hall F, Case Theater


Room C147


2:00-3:15 PS.06 How the Postgenome Era Will Change the Practice of Cardiology Hall E

ATE.612 PFO and ASD Closure Room D226

2:00-5:00 AOS.103.01F Echocardiography for Prognosis and Outcomes in Aortic and Mitral Valve Disease Elm Fork Room

2:00-5:10 AOS.212.01 Cardiovascular Risk Prediction and Multimarker Approaches Room D167


AOS.802.01 Emerging Technologies for Treating Vascular, Valvular and Myopathic Disease Room D162

AOS.720.01 Hypertension: Clinical—Novel Classification, Assessment and Treatment of Essential Hypertension Room C150

AOS.518.01 Hypertrophic Cardiomyopathy: Novel Treatment and Outcomes Hall B-9



5:30-6:45 CVS.111 Advances in Nuclear Cardiology Elm Fork Room


CVS.519 Challenges in the Diagnosis and Management of Cardiomyopathy Hall B-7

CVS.319 Contemporary Challenges in Drug Safety in an Era of Personalized Medicine Hall B-3

CVS.110 Emerging Role of Imaging in Cardio-Oncology Clear Fork Room


CVS.614 Joint AHA/Egyptian Society of Cardiology Session: Advanced Interventional Techniques Room D226

ATE.505 New Insights and Challenges in Pulmonary Hypertension with Left-Heart Failure Hall B-6

ATE.613 Venous Thromboembolic Disease: When Do We Go Beyond Anticoagulation? Room D223




TRACKS


Tracks

GENERAL CARDIOLOGY AND STRUCTURAL HEART DISEASE (cont.)Wednesday Nov 20

7:30-8:45 CVS.527 Cardiac Amyloidosis and Infiltrative Disease: New Frontiers and Insights in Diagnosis and Management Room D167

CVS.318 Challenging Imaging Diagnoses: What Tools Are Available? Ballroom A4

CVS.725 Depression: Status as a Risk Factor in Acute Coronary Syndromes Room C144

CVS.615 Does It Make a Difference How You Think? Cardiovascular Disease and Cognition Room D222





CVS.617 Invasive Hemodynamic Tips and Tricks to Expedite Patient Care Room D226

ATE.406 Joint AHA/American Autonomic Society Session: Orthostatic Hypotension—An Emerging Epidemic Hall B-2

CVS.224 Joint AHA/American Society of Hypertension Session: Hypertension in the Elderly—Unmet Needs Room D170

CVS.112 Joint AHA/European Society of Cardiology Session: Real-World Challenges in Chronic Mitral Regurgitation

Clear Fork Room




CVS.522 Sleep and the Heart Hall B-8

ATE.407 Successful Approach to Fainting and Dizziness Hall B-4

CVS.317 The New Anticoagulants: Patient Education, Conversion, Management and Pharmacoeconomics— Is It Worth It?

Ballroom A2


PS.08 The Cardiovascular Health and Prevention Agenda: 2013-2030 Ballrooms C1&C2

SS.15 The Legacy of Cardiovascular Disease for Cancer Survivors Room C147

9:00-12:00 APS.405.02h Clinical Cardiac Electrophysiology V Hall F, Core 4

APS.211.02 CVD Epidemiology: Socioeconomic Status, Race and Other Risk Factors Hall F, Core 2

APS.104.03 Echocardiography and Clinical Syndromes Hall F, Core 1


APS.104.04h Echocardiography in High-Risk Patients Hall F, Core 1

APS.720.04 Hypertension: Clinical—Gender, Kidney, Sleep, the Elderly and Blood Pressure Hall F, Core 7



APS.208.01 Preventive Interventions: Population and Clinical Trials Hall F, Core 2



AOS.109.01 Noncoronary Vascular Imaging Clear Fork Room


10:45-12:00 SS.16 Future Strategies and Targets for Heart Failure Room C147

CVS.813ic Potential Cardiotoxicity of Extreme Endurance Exercise Ballrooms C3&C4


TRACKS


Trac

ks

GENETICS/GENOMICSSaturday Nov 16

1:00-3:00 EC.06 How to Build a Road Map for Your Career in Functional Genomics and Translational Biology (Planned by the Council on Functional Genomics and Translational Biology)

Room D163


Room D163

Sunday Nov 17



Hall B-1




9:00-5:00 APS.501.01 Cation Regulation Disorders and Heart Failure Hall F, Core 5





3:45-4:45 AOS.300.02Y Functional Genomics and Translational Biology Young Investigator Award Finalists Ballroom A2

3:45-5:00 AOS.904.01Y Louis N. and Arnold M. Katz Basic Science Research Prize for Young Investigators Finalists Hall B-5

5:30-6:45 CVS.302 Epigenetics, Regulatory Sequence and Human Disease Ballroom A2



Monday Nov 18

7:30-8:45 ATE.302 Common Variants and Clinical Risk: dbSNP Versus dbBS Ballroom A2

ATE.301 Computational Approaches in Genomic Research Ballroom A3



Room C147

9:00-12:00 AOS.402.01N Thomas Smith Memorial Lecture and Subcellular Calcium Control and Arrhythmias Hall B-1

AOS.301.01 Epigenetic and Noncoding RNA Regulation in the Cardiovascular System Ballroom A2

9:00-5:00 APS.202.01 Familial Hypercholesterolemia and Other Lipid Disorders Hall F, Core 2


APS.304.02 Genetic Variation and Coronary Artery Disease Hall F, Core 3




AOS.304.01F Common and Rare Variants Associated with CAD and Risk Factors Ballroom A2

5:30-6:45 CVS.308 Circulation Cardiovascular Genetics/Functional Genomics and Translational Biology Ballroom A3




TRACKS


Tracks

GENETICS/GENOMICS (cont.)Tuesday Nov 19


CVS.215 Atrial Fibrillation: State of the Science Room D167

CVS.309 Epidemiology and Genetics of Adult Congenital Heart Disease: Insights from GenTAC, the National Registry of Genetically Triggered Aneurysms and Other Cardiovascular Conditions

Ballroom A4

CVS.311 Functional Genomics of Human Cardiac Disease Ballroom A2


Hall B-1


9:00-12:10 AOS.501.02 Fibroblast Modulation in Cardiac Remodeling Hall B-6


Room C143














2:00-5:10 AOS.302.01 Developmental and Reactive Cardiomyocyte Growth Signaling Ballroom A2


AOS.723.01 Novel Signaling Pathways of Pulmonary Hypertension Room C144

5:30-6:45 CVS.519 Challenges in the Diagnosis and Management of Cardiomyopathy Hall B-7

CVS.313 Cracking the Noncode for RNA Ballroom A3

CVS.521 MicroRNA as Diagnostic and Therapeutic Tools Hall B-9

Wednesday Nov 20




AOS.519.01 Basic and Clinical Insights in Valvular Disease Hall B-7



TRACKS


Trac

ks

GLOBAL CONGRESS ON PHYSICAL ACTIVITYSaturday Nov 16

1:00-3:45 EC.01ic Developing a Career in Physical Activity Research: Is Funding Available? Room C146

Sunday Nov 17

8:00-10:50 SMP.100ic Current State of Physical Activity Patterns and Burden of Disease: A Global Perspective Ballrooms C3&C4

9:00-5:00 APS.207.03 Exercise/Physical Activity: Basic Aspects Hall F, Core 2

3:45-5:00 CVS.801ic Stemming the Tide: The Role of Physical Activity in Reversing the Obesity and Diabetes Epidemic Ballrooms C3&C4

5:30-6:45 CVS.802ic ASPEN TIMEOUT: How Can Sports Best Produce a Physically Active Lifestyle? Ballrooms C3&C4


Monday Nov 18

7:30-8:45 ATE.801ic Creative Approaches to Improving Physical Activity: The Power of Technology and Play for All Ages Ballrooms C3&C4

9:00-10:15 CVS.803ic The Future of Physical Education Programs in the School Systems: A Global Perspective Ballrooms C3&C4

9:00-5:00 APS.207.02 Clinical Aspects of Exercise, Physical Activity and Rehabilitation Hall F, Core 2

10:45-12:00 ATE.802ic Promoting Physical Activity Through Worksite Wellness Programs Ballrooms C3&C4

2:00-3:15 PS.03ic Solving the Obesity/Type 2 Diabetes Epidemic: The Role of Physical Activity/Exercise Hall E


3:45-5:30 SS.17ic The Emergence of Physical Fitness and Activity as a Primary Health Indicator: A Historical Perspective from the Cooper Clinic

Ballrooms C3&C4

5:30-6:45 CVS.211 State of Exercise Science for Cardiovascular Health Promotion: Methods, Measures and Interventions Room D168

5:45-6:45 CVS.804ic The Physician’s Role in Assessing and Promoting Physical Activity in the Clinical Setting Ballrooms C3&C4

Tuesday Nov 19

7:30-8:45 CVS.805ic Physical Activity and Bench-to-Bedside Research: Cellular Discoveries and Implications for Clinical Practice

Ballrooms C3&C4

9:00-10:15 CVS.806ic Critical Review of Tools to Use for Assessing Physical Activity Ballrooms C3&C4

10:45-12:00 CVS.807ic Determinants of Patterns of Physical Activity Behaviors Across the Life Course and Diverse Populations

Ballrooms C3&C4

2:00-3:15 CVS.808ic From Bench to Bedside: Novel Insights into the Role of Exercise in the Treatment of Heart Disease Ballrooms C3&C4

3:45-5:00 CVS.809ic Assessing Physical Activity, Cardiorespiratory Fitness or Both as “Vital Signs” in the Primary Care Setting

Ballrooms C3&C4

5:30-6:45 CVS.810ic Web-Based Physical Activity Tools from Professional Organizations: AHA Start Walking Now and ACSM Exercise Is Medicine

Ballrooms C3&C4

Wednesday Nov 20

7:30-8:45 ATE.207 Improving Patient Adherence to Treatment Recommendations Room D168

CVS.811ic Physical Activity in Special Populations: Where Are We and Where Are We Going? Ballrooms C3&C4



9:00-12:00 APS.211.02 CVD Epidemiology: Socioeconomic Status, Race and Other Risk Factors Hall F, Core 2

10:45-12:00 CVS.813ic Potential Cardiotoxicity of Extreme Endurance Exercise Ballrooms C3&C4


TRACKS


Tracks

HEART FAILURESunday Nov 17

8:00-11:00 SMP.505 Acute Heart Failure: A New Era or Same Old Problems? Hall B-7

SMP.506 Emerging Posttranslational Modifications in Heart Failure Hall B-9


SMP.102 Imaging Cardiomyopathy Clear Fork Room






9:00-5:00 APS.507.01 Advanced Heart Failure and Heart Transplantation Hall F, Core 5

APS.217.01 Cancer and Cardiovascular Disease I Hall F, Core 2

APS.514.05h Cardioprotection: Mechanisms of Ischemia-Reperfusion Injury Hall F, Core 5





Hall F, Core 2

APS.611.02 Clinical Issues in Heart Failure and Transplantation Hall F, Core 6






APS.506.01 Diuretic Management and Nutritional Status in Heart Failure Hall F, Core 5


APS.211.03 Epidemiology of Heart Failure Hall F, Core 2




APS.506.04 Heart Failure Outcomes in Diverse Settings and Populations Hall F, Core 5

APS.505.01 Heart Failure: CRT, Pacing, Sleep Apnea and Outcomes Hall F, Core 5

APS.503.04 Heart Failure: Pathophysiology and Diagnosis I Hall F, Core 5

APS.504.03 Heart Failure: Pharmacological Therapy I Hall F, Core 5

APS.504.01 Heart Failure: Pharmacological Therapy—Ischemia and Infarction Hall F, Core 5



APS.503.03 Molecular Markers of Heart Failure Hall F, Core 5








APS.301.02 Signaling Pathways in Heart Disease Hall F, Core 3


TRACKS


Trac

ks

9:00-5:00 APS.105.01 Translational Molecular Imaging: Novel Probes and Advanced Clinical Applications Hall F, Core 1

SS.02 Joint AHA/ACC Session: ACCF/AHA Guidelines for Management of Chronic Heart Failure: 2013 Update

Ballrooms C1&C2

5:30-6:45 CVS.501 Cardiac Fibroblasts Hall B-6

ATE.502 Controversies and Challenges in Heart Transplant Hall B-9







Monday Nov 18



CVS.404 Management of Frequent Ventricular Ectopy Hall B-4

CVS.507 Mechanical Options in Acutely Decompensated Heart Failure Hall B-5





AOS.722.01N Stroke Council Award and Lecture and Prediction and Prognostication in Stroke: Clinical Aspects

Room C144



AOS.501.01 Cardiometabolic Mechanisms in Heart Failure Hall B-6


AOS.301.01 Epigenetic and Noncoding RNA Regulation in the Cardiovascular System Ballroom A2

AOS.506.01 Heart Failure: Clinical Outcomes and Comorbid Conditions Hall B-9

AOS.506.02 Heart Failure: Latest Clinical Science in Preserved Ejection Fraction Hall B-5

AOS.505.01 Heart Failure: Pacing, Outcomes and Future Device Interventions Hall B-7

9:00-5:00 APS.506.05 Acute Heart Failure and Readmission Hall F, Core 5

APS.404.04 Arrhythmia Management Hall F, Core 4

APS.517.02h Biomarkers in Assessment of Changes in LV Function and Heart Failure: Role of Comorbidities, Filling Pressures and Heart Failure Status

Hall F, Core 5

APS.718.01 Cardiorenal Physiology/Pathophysiology I Hall F, Core 7



APS.506.02 Clinical Outcomes in Heart Failure Hall F, Core 5




APS.505.02 Heart Failure: Pacing and Other Therapeutic Devices Hall F, Core 5

APS.504.02 Heart Failure: Pharmacological Therapy II Hall F, Core 5

APS.504.04 Heart Failure: Pharmacological Therapy III Hall F, Core 5

APS.404.06 Heart Rhythm Disorders: Clinical Features Hall F, Core 4

HEART FAILURE (cont.)


TRACKS


Tracks

9:00-5:00 APS.501.06 Immune and Inflammatory Mechanisms in Heart Failure Hall F, Core 5

APS.507.02 Left Ventricular Assist Device Patient Selection and Management Hall F, Core 5


APS.509.02 Molecular Signaling in Cardiac Hypertrophy Hall F, Core 5




APS.310.01 Pediatric Heart Failure Hall F, Core 3


APS.506.03 Prognostic Indicators in Heart Failure Hall F, Core 5







PS.02 Joint AHA/American Society of Echocardiography Session: Imaging Preclinical Cardiovascular Disease

Ballrooms C1&C2

2:00-5:10 AOS.517.01 How to Assess and Improve Left Ventricular Function and Heart Failure: From Left Ventricular Mechanics and Arterial Compliance to Biomarkers

Hall B-7






CVS.510 Heart Rate Reduction as a Therapeutic Target in Heart Failure Hall B-6

Tuesday Nov 19

7:30-8:45 ATE.504 Controversies and Challenges in Heart Failure Pharmacotherapy Hall B-5


CVS.516 Myofibrillar Proteins in Heart Failure Hall B-8





AOS.501.02 Fibroblast Modulation in Cardiac Remodeling Hall B-6

9:00-12:10 AOS.303.01 Multiscale Omics Reveals New Mechanisms of Cardiovascular Disease Ballroom A2


AOS.310.01 Pediatric Heart Failure: Prognosis and Treatment from Infusion to Transplant Ballroom A4

AOS.507.01 Promoting Survival Following MCS and Heart Transplantation Hall B-8



APS.724.01 Autonomic Control and Regulation Hall F, Core 7

APS.728.01 Biomarkers Hall F, Core 7

APS.516.01 Calcium, Mitochondrial Remodeling and Mitophagy Hall F, Core 5




TRACKS


Trac

ks

9:00-5:00 APS.404.7987 Clinical Cardiac Electrophysiology III Hall F, Core 4

APS.501.07 Clinical Measurements and Outcomes in Patients with Heart Failure Hall F, Core 5





APS.503.02 Heart Failure: Pathophysiology and Diagnosis II Hall F, Core 5

APS.503.05 Heart Failure: Pathophysiology and Diagnosis III Hall F, Core 5






APS.517.01 Novel Circulatory Biomarkers and Regulatory Proteins in Heart Failure Hall F, Core 5

APS.501.04 Novel Receptor Signaling Mechanisms and Heart Failure Hall F, Core 5



APS.508.01h Pulmonary Circulation and Right Ventricle Hall F, Core 5


APS.506.06 Predicting Mortality in Heart Failure Hall F, Core 5

10:00-10:45 CT.06 Learning at the Movies: Management of Hypertrophic Obstructive Cardiomyopathy: A Heart Team Approach


2:00-3:15 SS.14 Enhancing Response to Resynchronization Therapy Ballrooms C1&C2



AOS.212.01 Cardiovascular Risk Prediction and Multimarker Approaches Room D167


AOS.302.01 Developmental and Reactive Cardiomyocyte Growth Signaling Ballroom A2

AOS.504.01 Heart Failure: Neurohormonal Therapy Revisited Hall B-5

AOS.503.01 Heart Failure: Pathophysiology and Biomarkers Hall B-7

AOS.503.02 Heart Failure: Pathophysiology and Diagnosis Hall B-8

AOS.518.01 Hypertrophic Cardiomyopathy: Novel Treatment and Outcomes Hall B-9

AOS.514.02 Novel Mechanisms of Cardioprotection and Stem Cell–Mediated Repair Hall B-6

AOS.723.01 Novel Signaling Pathways of Pulmonary Hypertension Room C144




CVS.520 Calcium Cycling in Heart Failure Hall B-5

CVS.720 cGMP-Mediated Regulation of Systemic Blood Pressure: Recent Advances and Implications for Treatment Room C146








TRACKS


Tracks

Wednesday Nov 20


CVS.523 Cardiac-Based Gene Therapies Hall B-5



CVS.526 Metabolic Signaling in the Cardiac System Room D223





APS.514.03 Cardioprotection: Pre-, Peri-, and Postconditioning Hall F, Core 5













HYPERTENSION AND KIDNEY DISEASESunday Nov 17

8:00-11:00 SMP.703 Hypertensive Emergencies and Urgencies Room C150

9:00-5:00 APS.720.01 Hypertension: Clinical—Heart, Oxygen and Blood Pressure Hall F, Core 7






5:30-6:45 CVS.201 How Should We Conduct Cardiovascular Disease Trials? Room D170

Monday Nov 18





9:00-12:10 AOS.719.01 Hypertension: Experimental—Immune Mechanisms/Vascular and Neural Control Mechanisms Room C150



TRACKS


Trac

ks

9:00-5:00 APS.210.01 Diabetes Mellitus and CVD: Clinical Studies Hall F, Core 2



APS.719.01 Hypertension: Experimental Hall F, Core 7



BASC.06 Best of AHA Specialty Conferences: HBPR 2013 Hall F




5:30-6:45 CVS.712 Angiogenesis in Pulmonary Arterial Hypertension: Friend or Foe? Room C146

Tuesday Nov 19

7:30-8:45 CVS.718 Incretin Hormones in CVD: New Kids on the Block Room C143

CVS.715 Joint AHA/International Society of Vascular Health Session: Arterial Stiffness in Specific Populations Room C150

9:00-12:10 AOS.718.01 Cardiorenal Physiology/Pathophysiology II Room C146

9:00-5:00 APS.212.12 Chronic Kidney Disease and CVD Hall F, Core 2

APS.720.03 Hypertension: Clinical—Drug Treatment, Measurement and Blood Pressure Hall F, Core 7




10:45-12:00 SS.11 Sympathetic Renal Denervation for Drug-Resistant Hypertension Ballrooms C1&C2

2:00-5:00 AOS.708.01F Translational Insights in the Regulation of Vascular Resistance in Health and Disease Room C146

2:00-5:10 AOS.720.01 Hypertension: Clinical—Novel Classification, Assessment and Treatment of Essential Hypertension Room C150



5:30-6:45 CVS.720 cGMP-Mediated Regulation of Systemic Blood Pressure: Recent Advances and Implications for Treatment Room C146

CVS.721 Fundamental Mechanisms of Hypertension Room C150

Wednesday Nov 20

7:30-8:45 ATE.406 Joint AHA/American Autonomic Society Session: Orthostatic Hypotension—An Emerging Epidemic Hall B-2

CVS.224 Joint AHA/American Society of Hypertension Session: Hypertension in the Elderly—Unmet Needs Room D170


CVS.727 Rapid Nongenomic Mineralocorticoid Receptor Effects on Cardiovascular Function Room C146

9:00-10:15 PS.08 The Cardiovascular Health and Prevention Agenda: 2013-2030 Ballrooms C1&C2

9:00-12:00 APS.211.02 CVD Epidemiology: Socioeconomic Status, Race and Other Risk Factors Hall F, Core 2



9:00-12:10 AOS.208.01 Novel Insights from Clinical Trials and Preventive Interventions Room D170


HYPERTENSION AND KIDNEY DISEASE (cont.)


TRACKS


Tracks

IMAGINGSaturday Nov 16

1:00-5:00 EC.10 Cardiac Imaging Boot Camp (Planned by the Council on Cardiovascular Radiology and Intervention) Room D170

Sunday Nov 17

8:00-11:00 SMP.102 Imaging Cardiomyopathy Clear Fork Room








APS.101.01 Echocardiography: Right-Heart Function and Pressures Hall F, Core 1



APS.105.01 Translational Molecular Imaging: Novel Probes and Advanced Clinical Applications Hall F, Core 1

3:45-5:00 AOS.100.01Y Melvin Judkins Young Investigator Award Finalists Elm Fork Room

5:30-6:45 CVS.101 State of the Art in Cardiac Computed Tomography Elm Fork Room

Monday Nov 18

7:30-8:45 ATE.102 Image-Guided Therapy West Fork Room



9:00-10:15 PS.01 Heart Valve Disease: State of the Science and Controversies Hall E


AOS.105.01F Emerging Role of PET Biomarkers in Cardiovascular Disease West Fork Room




9:00-5:00 APS.106.04 Cardiac CT Hall F, Core 1




APS.108.02 Disease Prognosis by Cardiac MR Imaging II Hall F, Core 1

APS.102.04 Echocardiography: Clinical Applications of Myocardial Strain Imaging Hall F, Core 1

APS.102.02 Echocardiography: Contrast Imaging and Myocardial Function Hall F, Core 1






APS.306.01 Pediatric Imaging: Ventricular Volume, Mass and Function Hall F, Core 3

APS.203.02 Stress Testing Exercise and Pharmacologic Hall F, Core 2





AOS.104.01F Stress Echocardiography: New Insights Elm Fork Room


TRACKS


Trac

ks

2:00-5:10 AOS.108.02 Cardiac MR Imaging II West Fork Room





5:30-6:45 CVS.106 Advances in Echocardiography Clear Fork Room

CVS.104 Cardiac MRI 2013: Putting Your Best Spin on It Elm Fork Room



Tuesday Nov 19

7:30-8:45 ATE.103 Challenges in Imaging Aortic Valve Disease Clear Fork Room

CVS.107 Imaging in Potential Novel Therapies for Cardiovascular Diseases West Fork Room

CVS.108 In Search of the Culprit Lesion: Utility of Imaging Elm Fork Room

7:30-8:45 CVS.719 The Multiple Different Facets of Fibromuscular Dysplasia Room C146


9:00-12:10 AOS.102.02 Clinical Applications of Advanced Echocardiographic Imaging Elm Fork Room





APS.103.01 Echocardiography for the Evaluation and Treatment of Structural Heart Disease Hall F, Core 1




APS.108.06 MR Imaging in Clinical Syndromes Hall F, Core 1

APS.108.04 MR Imaging of Cardiac Structure Hall F, Core 1



APS.704.02 Smooth Muscle Cells and Intimal Hyperplasia Hall F, Core 7


Room C147


AOS.103.01F Echocardiography for Prognosis and Outcomes in Aortic and Mitral Valve Disease Elm Fork Room









IMAGING (cont.)


TRACKS


Tracks

Wednesday Nov 20


CVS.318 Challenging Imaging Diagnoses: What Tools Are Available? Ballroom A4



CVS.112 Joint AHA/European Society of Cardiology Session: Real-World Challenges in Chronic Mitral Regurgitation Clear Fork Room


9:00-12:00 APS.104.03 Echocardiography and Clinical Syndromes Hall F, Core 1


APS.104.04h Echocardiography in High-Risk Patients Hall F, Core 1





APS.512.01 Ventricular Function/Mechanics Hall F, Core 5


AOS.306.01 Pediatric Imaging: Function and Flow Ballroom A4

INTERVENTIONAL CARDIOLOGYSaturday Nov 16

1:00-5:00 EC.09 Interventional Cardiology Fellows Program Room D226


Sunday Nov 17


8:00-11:00 SMP.705 Critical Limb Ischemia as a Public Health Priority Room C143







APS.601.01 Platelet Function and Antiplatelet Therapy Hall F, Core 6

APS.602.02 Predicting Success and Failure with Stents and PCI Hall F, Core 6

APS.605.01 Percutaneous Noncoronary Cardiac Intervention (Non-TAVR) Hall F, Core 6

9:30-11:00 SMP.603 Interventional Cardiology: The Best Trials of 2013 Room D226


3:45-5:00 CVS.601 New Approaches for Treating Coronary CTOs Room D226

4:00-4:45 CT.02 Learning at the Movies: Endovascular Atherectomy for Patient with Peripheral Artery Disease (PAD) Hall F, Case Theater

5:30-6:45 ATE.602 I Wish I Could Have Avoided That Complication! Room D226


IMAGING (cont.)


TRACKS


Trac

ks

Monday Nov 18

7:30-8:45 ATE.102 Image-Guided Therapy West Fork Room

CVS.603 PCI and Atrial Fibrillation: The Triple Therapy Dilemma Room D227

ATE.604 Uncommon Structural Interventions Room D226

9:00-10:15 PS.01 Heart Valve Disease: State of the Science and Controversies Hall E

ATE.605 PCI Guided by OCT, IVUS and FFR: What You Need to Know Room D226


9:00-12:00 AOS.602.01F Trends, Outcomes and Quality Improvement in PCI Room D222



9:00-5:00 APS.606.03 Catheter-Based Coronary Imaging and Hemodynamics III Hall F, Core 6


Hall F, Core 2

APS.602.03 Coronary Interventions: Risky Patients and Risky Lesions Hall F, Core 6


APS.602.01 Next Generation Stents, Polymers and Approaches Hall F, Core 6

APS.605.04 Percutaneous Noncoronary Cardiac Intervention (Including Percutaneous Valves) Hall F, Core 6

APS.605.02 Transcatheter Aortic Valve Replacement I Hall F, Core 6

10:45-12:00 CVS.605 My Worst Complication of the Year: Needing a Mulligan Room D226


CVS.606 Primary PCI: State of the Art Room D226

2:00-4:30 MOC.02 Maintenance of Certification: ABIM Learning Session—Interventional Cardiology 2013 Update (B2-P) Room C155

2:00-5:10 AOS.608.01 Surgical Revascularization for Ischemic Heart Disease I Room D227



3:00-3:45 CT.04 Learning at the Movies: VT Ablation—State of the Art 2013 Hall F, Case Theater

3:45-5:00 CVS.607 Endovascular Approaches to Peripheral Vascular Disease Room D226


5:30-6:45 CVS.609 Multidisciplinary Hemodynamics Room D226

CVS.608 The Ongoing Conundrum of Superficial Femoral Artery Disease Room D227

Tuesday Nov 19


7:30-8:45 ATE.609 Asymptomatic Severe Carotid Artery Stenosis: What Is the Best Management? Room D227

ATE.608 Radial Access: Meet the Experts Room D226

CVS.719 The Multiple Different Facets of Fibromuscular Dysplasia Room C146


9:00-10:15 ATE.610 Critical Skills for the Structural Interventionalist Room D226

9:00-12:10 AOS.603.01 Novel Approaches and Technologies in AMI and Coronary Intervention Room D223

9:00-5:00 APS.602.05 Catheter-Based Coronary Interventions: Technologies and Outcomes Hall F, Core 6

APS.603.01 Drug-Eluting Stents: New Technology and Challenging Subgroups Hall F, Core 6

APS.601.02 Optimizing PCI Outcomes Hall F, Core 6



APS.603.02h The Full Spectrum of Interventional Cardiology Procedures Hall F, Core 6


INTERVENTIONAL CARDIOLOGY (cont.)


TRACKS


Tracks

9:00-5:00 APS.605.03 Transcatheter Aortic Valve Replacement II Hall F, Core 6

10:00-10:45 CT.06 Learning at the Movies: Management of Hypertrophic Obstructive Cardiomyopathy: A Heart Team Approach


10:45-12:00 ATE.611 How I Would Treat This CTO: Basic and Advanced Techniques Room D226

SS.11 Sympathetic Renal Denervation for Drug-Resistant Hypertension Ballrooms C1&C2

2:00-3:15 ATE.612 PFO and ASD Closure Room D226

2:00-5:00 AOS.103.01F Echocardiography for Prognosis and Outcomes in Aortic and Mitral Valve Disease Elm Fork Room

2:00-5:10 AOS.801.01 Case Studies: Finding a Needle in a Haystack Room D227


AOS.601.01 Optimizing Pharmacology for Complex PCI Patients Room D223

3:45-5:00 CVS.612 How to Set Up a Same-Day Discharge Program for PCI Room D226

5:30-6:45 CVS.614 Joint AHA/Egyptian Society of Cardiology Session: Advanced Interventional Techniques Room D226


Wednesday Nov 20

7:30-8:45 CVS.617 Invasive Hemodynamic Tips and Tricks to Expedite Patient Care Room D226


9:00-10:15 CVS.618 Scientific Update on Radial Access Room D226

9:00-12:00 APS.608.02 Surgical Revascularization for Ischemic Heart Disease III Hall F, Core 6

10:45-12:00 ATE.614 Running a Successful TAVR Program Room D226

MYOCYTE SIGNALING AND ION CHANNELSSaturday Nov 16


Room C143

3:00-4:45 EC.16 Mission Possible: Keys to Early Career Academic Succes—Part 2 (Planned by the Council on Basic Cardiovascular Sciences)

Room C143

Sunday Nov 17


SMP.506 Emerging Posttranslational Modifications in Heart Failure Hall B-9



Hall B-1




9:00-5:00 APS.514.05h Cardioprotection: Mechanisms of Ischemia-Reperfusion Injury Hall F, Core 5



APS.501.01 Cation Regulation Disorders and Heart Failure Hall F, Core 5


APS.401.01 Mechanisms Regulating Ion Channel Expression and Trafficking Hall F, Core 4

APS.209.03 Obesity in CVD Risk and Prevention: Basic Studies Hall F, Core 2



APS.301.02 Signaling Pathways in Heart Disease Hall F, Core 3

APS.403.23 Sinus Node Dysfunction and Atrial Arrhythmias Hall F, Core 4

INTERVENTIONAL CARDIOLOGY (cont.)


TRACKS


Trac

ks





CVS.501 Cardiac Fibroblasts Hall B-6




Monday Nov 18


CVS.508 Molecular Signaling in Cardiac Development and Diseases Hall B-8


9:00-12:00 AOS.402.01N Thomas Smith Memorial Lecture and Subcellular Calcium Control and Arrhythmias Hall B-1

9:00-12:10 AOS.501.01 Cardiometabolic Mechanisms in Heart Failure Hall B-6


9:00-5:00 APS.403.03 Cardiac Repolarization and Ventricular Arrhythmias Hall F, Core 4





APS.723.02 Pulmonary Hypertension: Pathogenetic Mechanisms Hall F, Core 7







5:30-6:45 CVS.306 Bystander or Player? SCN10A in Cardiac Conduction Ballroom A2

CVS.513 Cardiomyocyte Renewal Hall B-5



Tuesday Nov 19

7:30-8:45 CVS.411 Genetics, Mechanism and Therapy of Conduction Block Hall B-4

CVS.516 Myofibrillar Proteins in Heart Failure Hall B-8


9:00-12:10 AOS.512.01 Ventricular Function/Mechanics: Contractility and Biophysics Hall B-9



APS.403.04 Cellular/Molecular Mechanisms of Atrial Fibrillation Hall F, Core 4



9:00-5:00 APS.517.01 Novel Circulatory Biomarkers and Regulatory Proteins in Heart Failure Hall F, Core 5


APS.402.02 Sarcolemmal Ion Channels and Arrhythmias Hall F, Core 4


2:00-5:10 AOS.514.02 Novel Mechanisms of Cardioprotection and Stem Cell–Mediated Repair Hall B-6

MYOCYTE SIGNALING AND ION CHANNELS (cont.)


TRACKS


Tracks

5:30-6:45 CVS.520 Calcium Cycling in Heart Failure Hall B-5




Wednesday Nov 20

7:30-8:45 CVS.525 Inflammation in Cardiac Disease and Remodeling Hall B-9


9:00-12:00 APS.514.03 Cardioprotection: Pre-, Peri-, and Postconditioning Hall F, Core 5

APS.403.01 Experimental Models of Cardiac Arrhythmias Hall F, Core 4

APS.515.01h Mechanisms of Cell Death and Translational Implications Hall F, Core 5

9:00-12:10 AOS.515.01 Mechanisms of Cardiomyocyte Death and Survival Hall B-8


PERIPHERAL VASCULAR DISEASESaturday Nov 16

8:00-5:20 EC.21 Peripheral Vascular Disease—Fellows in Training Workshop Ballroom A1

Sunday Nov 17

8:00-11:00 SMP.705 Critical Limb Ischemia as a Public Health Priority Room C143






9:00-5:00 APS.604.01 Claudication, Aortoiliac Disease, Ankle Brachial Index Hall F, Core 6



APS.720.01 Hypertension: Clinical—Heart, Oxygen and Blood Pressure Hall F, Core 7






5:30-6:45 ATE.601 Endovascular Aortic Therapies Room D222


CVS.704 What Makes the Pulmonary Circulation Unique from the Systemic Circulation? Room C143

Monday Nov 18

7:30-8:45 CVS.709 Challenges in Acute and Chronic Thromboembolic Disease Room C140


ATE.701 Management Challenges in Stroke: The Experts Discuss Tough Cases Room C143

CVS.708 Thoracic Aortic Disease: Etiology, Pathology, Imaging and Care Room C144




AOS.719.01 Hypertension: Experimental—Immune Mechanisms/Vascular and Neural Control Mechanisms Room C150

MYOCYTE SIGNALING AND ION CHANNELS (cont.)


TRACKS


Trac

ks


















PS.04 Novel Oral Anticoagulants: Clinical Conundra Hall E


5:30-6:45 CVS.713 Emerging Paradigms in Progenitor Cell Therapy and Vascular Repair Room C143




Room C144

CVS.608 The Ongoing Conundrum of Superficial Femoral Artery Disease Room D227


Tuesday Nov 19


CVS.309 Epidemiology and Genetics of Adult Congenital Heart Disease: Insights from GenTAC, the National Registry of Genetically Triggered Aneurysms and Other Cardiovascular Conditions

Ballroom A4


ATE.606 Managing Bleeding in Anticoagulated Patients: New Oral Anticoagulants and New Issues Room D223


9:00-12:10 AOS.714.01 Peripheral Arterial Disease, Myopathy, Lipid and Cellular Modulation Room C144


9:00-5:00 APS.720.03 Hypertension: Clinical—Drug Treatment, Measurement and Blood Pressure Hall F, Core 7









PERIPHERAL VASCULAR DISEASE (cont.)


TRACKS


Tracks





5:30-6:45 CVS.222 Debate: Can We Agree on Approaches to Risk Assessment? Room D167




Wednesday Nov 20

7:30-8:45 ATE.105 How to Image Vessel Wall and Atherosclerosis West Fork Room




9:00-12:00 APS.714.04 Aneurysmal Disease; Vasculopathies Hall F, Core 7









AOS.706.01 Novel Mechanisms and Therapeutics in Angiogenesis Room C140



PHARMACOLOGYSunday Nov 17

8:00-11:00 SMP.301 Personalized Medicine: Pharmacogenomics and Metabolomics—Is That Your Final Answer? Ballroom A3


9:00-5:00 APS.216.03 Clinical and Hospital-Based Observational Studies: Congestive Heart Failure, Atrial Fibrillation and Cardiac Surgery

Hall F, Core 2

APS.723.01 Emerging Therapeutic Targets of Pulmonary Vascular Diseases Hall F, Core 7

APS.609.01 Myocardial Protection, Intraoperative Management and Postoperative Critical Care Hall F, Core 6




APS.601.01 Platelet Function and Antiplatelet Therapy Hall F, Core 6





PERIPHERAL VASCULAR DISEASE (cont.)


TRACKS


Trac

ks

Monday Nov 18

7:30-8:45 CVS.603 PCI and Atrial Fibrillation: The Triple Therapy Dilemma Room D227


Room C147






5:30-6:45 CVS.407 Impact of Medical Gases on Ischemia-Reperfusion and Cardiac Arrest Outcomes Hall B-2



Room C144

Tuesday Nov 19

7:30-8:45 ATE.504 Controversies and Challenges in Heart Failure Pharmacotherapy Hall B-5



9:00-12:10 AOS.716.01N Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non– ST-Elevation ACS

Room C143




9:00-5:00 APS.216.02 Clinical and Hospital-Based Observational Studies: CVD Risk Factors Hall F, Core 2






2:00-5:10 AOS.503.02 Heart Failure: Pathophysiology and Diagnosis Hall B-8


AOS.601.01 Optimizing Pharmacology for Complex PCI Patients Room D223


5:30-6:45 CVS.319 Contemporary Challenges in Drug Safety in an Era of Personalized Medicine Hall B-3

CVS.619 Joint AHA/Caribbean Cardiac Society Session: Barriers to Adoption of New Pharmacologies in ACS Management—US and International Perspectives

Room D222

Wednesday Nov 20

7:30-8:45 CVS.317 The New Anticoagulants: Patient Education, Conversion, Management and Pharmacoeconomics—Is It Worth It?

Ballroom A2

9:00-12:00 APS.723.04 Biomarkers and Treatment for Pulmonary Hypertension Hall F, Core 7




PHARMACOLOGY (cont.)


TRACKS


Tracks

PREVENTION, BEHAVIOR CHANGE AND HEALTHY LIFESTYLESSaturday Nov 16


Room D223

1:00-3:45 EC.01ic Developing a Career in Physical Activity Research: Is Funding Available? Room C146


Room D223

Sunday Nov 17

8:00-10:50 SMP.100ic Current State of Physical Activity Patterns and Burden of Disease: A Global Perspective Ballrooms C3&C4






9:00-5:00 APS.214.01 Cardiovascular Disease in Diverse Populations Hall F, Core 2

APS.604.01 Claudication, Aortoiliac Disease, Ankle Brachial Index Hall F, Core 6






APS.206.02 Nutrition in CVD Risk: Basic Aspects Hall F, Core 2

3:45-5:15 AOS.200.02YN Robert Levy Memorial Lecture/Lifestyle and Cardiometabolic Health, formerly Council on Nutrition, Physical Activity and Metabolism (NPAM) Young Investigator Award Finalists

Room D163

5:30-6:45 CVS.802ic ASPEN TIMEOUT: How Can Sports Best Produce a Physically Active Lifestyle? Ballrooms C3&C4



Monday Nov 18


ATE.801ic Creative Approaches to Improving Physical Activity: The Power of Technology and Play for All Ages Ballrooms C3&C4

CVS.205 Latest Nutrition Trials: Recent Progress and Shortcomings Room D167



CVS.803ic The Future of Physical Education Programs in the School Systems: A Global Perspective Ballrooms C3&C4


9:00-12:10 AOS.206.01 Cardiometabolic Effects of Popular Diets Room D167

9:00-5:00 APS.207.02 Clinical Aspects of Exercise, Physical Activity and Rehabilitation Hall F, Core 2



APS.207.01 Exercise/Physical Activity and CVD Hall F, Core 2




APS.206.01 Nutrition in CVD Risk and Prevention Hall F, Core 2

APS.212.09 Risk Prediction for CVD and HIV-CVD Hall F, Core 2

BASC.02 Best of AHA Specialty Conferences: EPI/NPAM 2013 Hall F


TRACKS


Trac

ks

10:45-12:00 AOS.205.01 Approaches to Disease and Self-Management Room D168

ATE.802ic Promoting Physical Activity Through Worksite Wellness Programs Ballrooms C3&C4



PS.03ic Solving the Obesity/Type 2 Diabetes Epidemic: The Role of Physical Activity/Exercise Hall E

AOS.204.02 Symptoms and Symptom Management Room D168

CVS.227 Joint AHA/Brazilian Society of Cardiology Session: New Trends for Prevention and Diagnosis of Cardiovascular Disease

Room D170



3:45-5:30 SS.17ic The Emergence of Physical Fitness and Activity as a Primary Health Indicator: A Historical Perspective from the Cooper Clinic

Ballrooms C3&C4

5:30-6:45 CVS.212 Lowering ApoB-Containing Lipoproteins: Diversity of Therapeutic Targets Room D167

CVS.213 Outcomes Research 2.0: New Challenges and New Opportunities Room D162


Room D163



CVS.804ic The Physician’s Role in Assessing and Promoting Physical Activity in the Clinical Setting Ballrooms C3&C4

Tuesday Nov 19



CVS.217 Joint AHA/Asia Pacific Society of Cardiology Session: Noncommunicable Diseases— East Versus West

Room D170



ATE.305 Risk Factor Control in Patients with Congenital Heart Disease Ballroom A1

9:00-10:15 CVS.806ic Critical Review of Tools to Use for Assessing Physical Activity Ballrooms C3&C4

9:00-12:10 AOS.207.01 Physical Activity/Exercise Benefits: From Childhood to End-Stage Disease Room D163

9:00-5:00 APS.205.01 Comorbidities in Cardiovasular Disease Hall F, Core 2


APS.205.02 Depression and Stress in Heart Disease Hall F, Core 2



APS.209.01 Obesity-Associated Comorbidities Hall F, Core 2

10:45-12:00 AOS.204.01 Cognitive Function and Heart Failure Room D168

CVS.807ic Determinants of Patterns of Physical Activity Behaviors Across the Life Course and Diverse Populations Ballrooms C3&C4

2:00-3:15 CVS.808ic From Bench to Bedside: Novel Insights into the Role of Exercise in the Treatment of Heart Disease Ballrooms C3&C4

AOS.205.02 Strategies for Behavioral Change and Cardiovascular Risk Reduction Room D168



AOS.503.02 Heart Failure: Pathophysiology and Diagnosis Hall B-8


3:45-5:00 CVS.809ic Assessing Physical Activity, Cardiorespiratory Fitness or Both as “Vital Signs” in the Primary Care Setting

Ballrooms C3&C4

PREVENTION, BEHAVIOR CHANGE AND HEALTHY LIFESTYLES (cont.)


TRACKS


Tracks

5:30-6:45 ATE.206 Bringing Interventions to Diverse and Vulnerable Populations Room D168





CVS.810ic Web-Based Physical Activity Tools from Professional Organizations: AHA Start Walking Now and ACSM Exercise Is Medicine

Ballrooms C3&C4

Wednesday Nov 20








9:00-12:00 APS.205.04 Cardiovascular Disease: A Global Perspective Hall F, Core 2

APS.204.03 Cardiovascular Risk Hall F, Core 2

APS.211.02 CVD Epidemiology: Socioeconomic Status, Race and Other Risk Factors Hall F, Core 2



9:00-12:10 AOS.407.01 Implantable Cardioverter-Defibrillators: Management Issues and Therapy Hall B-1


PULMONARY & SYSTEMIC VASCULAR BIOLOGY AND DISEASESaturday Nov 16


Room C143


Room C143

Sunday Nov 17

8:00-11:00 SMP.702 Is It Time to Think Bigger About Microvascular Disease in the Heart? Room C146






9:00-5:00 APS.705.01 Controlling and Observing Stem Cell Behavior Hall F, Core 7





5:30-6:45 CVS.705 Hard Issues on Soft Tissues: Contributing Cells in Vascular Calcification Room C144


CVS.703 Leukocytes as Drivers of Atherosclerosis: Recent Advances Room C140



PREVENTION, BEHAVIOR CHANGE AND HEALTHY LIFESTYLES (cont.)


TRACKS


Trac

ks

Monday Nov 18


CVS.709 Challenges in Acute and Chronic Thromboembolic Disease Room C140

CVS.706 Inflammation, Immunity and Hypertension Room C150



BASC.03 Best of AHA Specialty Conferences: ATVB 2013 Hall F




APS.723.02 Pulmonary Hypertension: Pathogenetic Mechanisms Hall F, Core 7

APS.701.01 Regulators of Vascular Growth, Regeneration and Repair Hall F, Core 7





AOS.703.01 New Concepts in the Regulation of Vascular Endothelial Function Room C143






5:30-6:45 CVS.712 Angiogenesis in Pulmonary Arterial Hypertension: Friend or Foe? Room C146



Room D163


Tuesday Nov 19

7:30-8:45 CVS.716 Crosstalk Between Oxidation and Inflammation in Vascular Disease Room C144



9:00-12:10 AOS.502.01 Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure Hall B-5

9:00-5:00 APS.703.03 Novel Signaling Pathways in the Regulation of Endothelial Function Hall F, Core 7

APS.508.01h Pulmonary Circulation and Right Ventricle Hall F, Core 5



APS.607.01 Thoracic Aortic Disease I Hall F, Core 6



2:00-5:10 AOS.723.01 Novel Signaling Pathways of Pulmonary Hypertension Room C144






PULMONARY & SYSTEMIC VASCULAR BIOLOGY AND DISEASE (cont.)


TRACKS


Tracks

Wednesday Nov 20





9:00-12:00 APS.723.04 Biomarkers and Treatment for Pulmonary Hypertension Hall F, Core 7


APS.607.02 Thoracic Aortic Disease II Hall F, Core 6

9:00-12:10 AOS.701.01 Molecular Signals in Vascular Development and Disease Room C146


QUALITY OF CARE OUTCOMES AND EPIDEMIOLOGYSaturday Nov 16


Room C150


Room D223


Room D223

3:00-5:00 EC.15 Starting a Successful Career in Quality of Care and Outcomes Research (Planned by the Council on Quality of Care and Outcomes Research)

Room D222

Sunday Nov 17



SMP.705 Critical Limb Ischemia as a Public Health Priority Room C143



SMP.601 Patient Safety and Quality of Care in the Cardiac Operating Room Room D222




Hall F, Core 2






APS.213.01 Risk Prediction, Appropriateness and Health Economics: Quality of Care and Outcomes Hall F, Core 2



SS.02 Joint AHA/ACC Session: ACCF/AHA Guidelines for Management of Chronic Heart Failure: 2013 Update Ballrooms C1&C2

AOS.200.03Y Elizabeth Barrett-Connor Research Award for Young Investigators in Training Finalists Room D167

5:30-6:45 ATE.201 Achieving Accountability: How Will ACOs Impact the Delivery of Cardiovascular Care? Room D162


PULMONARY & SYSTEMIC VASCULAR BIOLOGY AND DISEASE (cont.)


TRACKS


Trac

ks

Monday Nov 18


CVS.208 Has the United States Lost Its Edge in Medical Innovation (and Why)? Room D162







9:00-12:00 AOS.602.01F Trends, Outcomes and Quality Improvement in PCI Room D222



AOS.408.01 Cardiac Arrest: Epidemiology and Clinical Outcomes Hall B-2

9:00-5:00 APS.718.01 Cardiorenal Physiology/Pathophysiology I Hall F, Core 7

APS.213.06 Cardiovascular Disease: Care Delivery and Outcomes Hall F, Core 2

APS.725.02 Chronic Coronary Artery Disease: Quality of Care and Outcomes Hall F, Core 7


Hall F, Core 2


APS.213.02 Improving Care in ACS, PCI and Cardiovascular Surgery Hall F, Core 2



BASC.02 Best of AHA Specialty Conferences: EPI/NPAM 2013 Hall F

BASC.04 Best of AHA Specialty Conferences: QCOR 2013 Hall F

10:45-12:00 SS.04 Stopping the No. 1 Killer of Women in the Second Decade of Go Red For Women Ballrooms C1&C2


SS.08 Success Story and Growing Challenge: Adult Congenital Heart Disease Ballrooms C3&C4

2:00-5:00 AOS.202.01N George L. Duff Memorial Lecture and Therapeutic Approaches for Treating Dyslipidemias Room D167

2:00-5:10 AOS.307.01 Tachycardia: Basic and Applied; Lipids and Hypertension Ballroom A4

AOS.213.02 Treatment Decisions for Coronary Artery Disease: Quality of Care and Outcomes Room D163

5:30-6:45 ATE.304 Improving ACHD Care Delivery Ballroom A1


Room C144

CVS.213 Outcomes Research 2.0: New Challenges and New Opportunities Room D162


Room D163

Tuesday Nov 19


CVS.215 Atrial Fibrillation: State of the Science Room D167

ATE.405 How to Improve Leadership and Teamwork in Resuscitation Hall B-2

ATE.204 Interpreting the Literature: A Primer on the Do’s and Don’ts Room D162

CVS.217 Joint AHA/Asia Pacific Society of Cardiology Session: Noncommunicable Diseases—East Versus West Room D170



QUALITY OF CARE OUTCOMES AND EPIDEMIOLOGY (cont.)


TRACKS


9:00-12:10 AOS.213.01 Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes Room D162

AOS.210.01 Diabetes Mellitus and CVD: Prevention and Management Room D170


Room C143



9:00-5:00 APS.216.02 Clinical and Hospital-Based Observational Studies: CVD Risk Factors Hall F, Core 2

APS.213.04 Medical Management: Atrial Fibrillation and Hypertension, Anticoagulants and Adherence Hall F, Core 2

APS.305.03 Pediatric Hypertension and Lipids; Late Implications of Adult Congenital Heart Disease Hall F, Core 3

APS.213.05 Race, Gender and Socioeconomic Differences in Cardiovascular Care Hall F, Core 2









5:30-6:45 ATE.205 Appropriately Implementing Appropriateness Use Criteria in Clinical Practice Room D162




CVS.614 Joint AHA/Egyptian Society of Cardiology Session: Advanced Interventional Techniques Room D226

Wednesday Nov 20





9:00-10:15 CVS.618 Scientific Update on Radial Access Room D226


9:00-12:00 APS.700.123 Cardiorenal Physiology/Pathophysiology Part II Hall F, Core 7


STROKE AND CEREBROVASCULAR DISEASESunday Nov 17

9:00-5:00 APS.721.01 Mechanisms of Brain Injury and Protection Hall F, Core 7

3:45-5:00 AOS.600.01Y Vivien Thomas Young Investigator Award Finalists Room D227


Monday Nov 18

7:30-8:45 ATE.701 Management Challenges in Stroke: The Experts Discuss Tough Cases Room C143




QUALITY OF CARE OUTCOMES AND EPIDEMIOLOGY (cont.)


TRACKS


9:00-5:00 APS.722.01 Heart-Brain Interactions: Clinical Aspects Hall F, Core 7


BASC.01 Best of AHA Specialty Conferences: ISC 2013 Hall F


Tuesday Nov 19

7:30-8:45 CVS.217 Joint AHA/Asia Pacific Society of Cardiology Session: Noncommunicable Diseases— East Versus West

Room D170



9:00-12:10 AOS.213.01 Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes Room D162


9:00-5:00 APS.724.01 Autonomic Control and Regulation Hall F, Core 7


APS.213.04 Medical Management: Atrial Fibrillation and Hypertension, Anticoagulants and Adherence Hall F, Core 2







5:30-6:45 CVS.414 Practical Issues in Postarrest Therapeutic Hypothermia Hall B-2

Wednesday Nov 20

9:00-12:00 APS.709.03 Hemostasis, Thrombosis and Coagulation Hall F, Core 7

9:00-12:10 AOS.724.01 Neurohormonal Regulation and Cardiovascular Control Room C143


SURGERYSaturday Nov 16


Room C150


Sunday Nov 17

8:00-11:00 SMP.601 Patient Safety and Quality of Care in the Cardiac Operating Room Room D222


9:00-5:00 APS.507.01 Advanced Heart Failure and Heart Transplantation Hall F, Core 5

APS.305.04 Basic Studies and Basic Care in HLHS Hall F, Core 3


APS.216.04 Clinical and Hospital-Based Observational Studies Hall F, Core 2


Hall F, Core 2

APS.611.02 Clinical Issues in Heart Failure and Transplantation Hall F, Core 6

APS.305.02 Congenital Heart Disease: Miscellaneous Aspects Hall F, Core 3

APS.503.04 Heart Failure: Pathophysiology and Diagnosis I Hall F, Core 5


STROKE AND CEREBROVASCULAR DISEASE (cont.)


TRACKS


9:00-5:00 APS.710.01 Myocardial Infarction: Novel Mechanisms of Injury and Repair Hall F, Core 7

APS.609.01 Myocardial Protection, Intraoperative Management and Postoperative Critical Care Hall F, Core 6


APS.610.01 Surgical Therapy for Valvular Heart Disease I Hall F, Core 6



5:30-6:45 CVS.401 Beyond Point-by-Point PVI: New Interventional Approaches to AF Ablation Hall B-4

ATE.502 Controversies and Challenges in Heart Transplant Hall B-9

ATE.601 Endovascular Aortic Therapies Room D222

ATE.602 I Wish I Could Have Avoided That Complication! Room D226




Monday Nov 18

7:30-8:45 CVS.507 Mechanical Options in Acutely Decompensated Heart Failure Hall B-5

CVS.604 Novel Insights in Degenerative Mitral Valve Disease: From Pathogenesis to Repair Room D223

ATE.303 Septating the Unbalanced Heart: Should We or Shouldn’t We? Ballroom A4


ATE.603 Update on Aortic Valve Repair Room D222


9:00-12:00 AOS.610.01N William W. L. Glenn Lecture and Surgical Therapy for Valvular Heart Disease II Room D227

9:00-12:10 AOS.309.01 Adult Congenital Heart Disease: Morbidity and Mortality with and Without Intervention Ballroom A3

AOS.308.01 Single-Ventricle Surgery: From Start to Fontan Ballroom A4

9:00-5:00 APS.507.02 Left Ventricular Assist Device Patient Selection and Management Hall F, Core 5





3:00-3:45 CT.04 Learning at the Movies: VT Ablation--State of the Art 2013 Hall F, Case Theater


AOS.308.02 Pediatric Heart Surgery: Perioperative Issues and Late Outcomes Ballroom A1





CVS.307 Controversies in Postoperative Care Ballroom A4

CVS.611 Minimally Invasive Cardiac Surgery: Where Are We in 2013? Room D223

Tuesday Nov 19


ATE.607 Controversies in Mitral Valve Repair for Degenerative Disease Room D222


SURGERY (cont.)


TRACKS


7:30-8:45 ATE.606 Managing Bleeding in Anticoagulated Patients: New Oral Anticoagulants and New Issues Room D223



9:00-12:10 AOS.305.05 Free Pulmonary Insufficiency and Other Daily Problems Ballroom A1


AOS.507.01 Promoting Survival Following MCS and Heart Transplantation Hall B-8


9:00-5:00 APS.609.02 Myocardial Protection and Postoperative Critical Care Hall F, Core 6

APS.308.02 Pediatric Cardiac Surgery: Peri- and Postoperative Issues Hall F, Core 3

APS.608.01 Surgical Revascularization for Ischemic Heart Disease II Hall F, Core 6

APS.610.02 Surgical Therapy for Valvular Heart Disease III Hall F, Core 6


10:00-10:45 CT.06 Learning at the Movies: Management of Hypertrophic Obstructive Cardiomyopathy— A Heart Team Approach


2:00-3:15 ATE.612 PFO and ASD Closure Room D226

5:30-6:45 CVS.314 Hypoplastic Left-Heart Syndrome: How Far Have We Come? Ballroom A1

CVS.613 Progress in Coronary Artery Surgery Room D227


Wednesday Nov 20

7:30-8:45 ATE.306 Infectious Diseases of the Heart: Updates on Old Problems Ballroom A1

CVS.112 Joint AHA/European Society of Cardiology Session: Real-World Challenges in Chronic Mitral Regurgitation Clear Fork Room



9:00-12:00 APS.309.02h Adult Congenital Heart Disease: Predictors of Outcome and Implications of Fontan Hall F, Core 3

APS.723.04 Biomarkers and Treatment for Pulmonary Hypertension Hall F, Core 7



9:00-12:10 AOS.609.01 Myocardial Protection and Surgical Critical Care Room D227

AOS.311.01 Single-Ventricle Cardiology: Palliation, Care and Resource Utilization Ballroom A3

SYSTEMS BIOLOGY/PHYSIOLOGY, INCLUDING OMICSSaturday Nov 16


Room C143

1:00-3:00 EC.06 How to Build a Road Map for Your Career in Functional Genomics and Translational Biology (Planned by the Council on Functional Genomics and Translational Biology)

Room D163


Room C143


Room D163

Sunday Nov 17

8:00-11:00 SMP.506 Emerging Posttranslational Modifications in Heart Failure Hall B-9



SURGERY (cont.)


TRACKS


9:00-5:00 APS.502.02 Cell and Tissue Engineering Therapies for Heart Failure Hall F, Core 5








5:30-6:45 CVS.302 Epigenetics, Regulatory Sequence and Human Disease Ballroom A2

CVS.102 Seamless Networks of Myocardial Bioenergetics West Fork Room


Monday Nov 18


ATE.301 Computational Approaches in Genomic Research Ballroom A3

9:00-12:10 AOS.719.01 Hypertension: Experimental—Immune Mechanisms/Vascular and Neural Control Mechanisms Room C150


APS.715.02 Atherogenesis and Myocardial Injury Hall F, Core 7

APS.802.01 From Microglia to Space Flight: Emerging Technologies in Neural, Vascular and Myocardial Disease Hall F, Core 2





BASC.05 Best of AHA Specialty Conferences: BCVS 2013 Hall F, Best of AHA Specialty Conferences


AOS.304.01F Common and Rare Variants Associated with CAD and Risk Factors Ballroom A2






5:30-6:45 CVS.306 Bystander or Player? SCN10A in Cardiac Conduction Ballroom A2

CVS.308 Circulation Cardiovascular Genetics/Functional Genomics and Translational Biology Ballroom A3




Tuesday Nov 19


Ballroom A4

CVS.311 Functional Genomics of Human Cardiac Disease Ballroom A2

CVS.517 New Advances in Cardiac Systems Biology Hall B-7

9:00-12:10 AOS.303.01 Multiscale Omics Reveals New Mechanisms of Cardiovascular Disease Ballroom A2


SYSTEMS BIOLOGY/PHYSIOLOGY, INCLUDING OMICS (cont.)


TRACKS


Trac

ks







9:00-5:00 APS.517.01 Novel Circulatory Biomarkers and Regulatory Proteins in Heart Failure Hall F, Core 5




5:30-6:45 CVS.520 Calcium Cycling in Heart Failure Hall B-5

CVS.313 Cracking the Noncode for RNA Ballroom A3


Wednesday Nov 20

7:30-8:45 CVS.728 Medical Management of Aneurysms: What Does the Evidence Show? Room C150



9:00-12:00 APS.802.02 Emerging Technologies in the Cellular and Pharmacological Therapies Hall F, Core 2









SYSTEMS BIOLOGY/PHYSIOLOGY, INCLUDING OMICS (cont.)

Documents

pic1.cmt.com.cnpic1.cmt.com.cn/newspic/files/2013AHA会议日程.pdfPurchase Sessions OnDemand™ Premium today and save $200 — in Lobby C and HeartQuarters Booth 339 TRACKS TIME